Sex, Drugs, and Rodent Reward: An Exploration of the Sex-Specific Roles of Nicotinic Acetylcholine Receptors in Ethanol Reward by Derner, Melissa Guildford
University of Massachusetts Medical School 
eScholarship@UMMS 
GSBS Dissertations and Theses Graduate School of Biomedical Sciences 
2016-12-08 
Sex, Drugs, and Rodent Reward: An Exploration of the Sex-Specific 
Roles of Nicotinic Acetylcholine Receptors in Ethanol Reward 
Melissa Guildford Derner 
University of Massachusetts Medical School 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/gsbs_diss 
 Part of the Behavioral Neurobiology Commons, and the Molecular and Cellular Neuroscience 
Commons 
Repository Citation 
Derner MG. (2016). Sex, Drugs, and Rodent Reward: An Exploration of the Sex-Specific Roles of Nicotinic 
Acetylcholine Receptors in Ethanol Reward. GSBS Dissertations and Theses. https://doi.org/10.13028/
M2C88B. Retrieved from https://escholarship.umassmed.edu/gsbs_diss/888 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in GSBS Dissertations and 
Theses by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
SEX, DRUGS, AND RODENT REWARD: AN EXPLORATION OF 
THE SEX-SPECIFIC ROLES OF NICOTINIC ACETYLCHOLINE 
RECEPTORS IN ETHANOL REWARD 
A Dissertation Presented  
By  
Melissa Guildford Derner  
Submitted to the Faculty of the  
University of Massachusetts Graduate School of Biomedical Sciences, 
Worcester  
in partial fulfillment of the requirements for the degree of  
DOCTOR OF PHILOSOPHY  
DECEMBER 8, 2016 
NEUROSCIENCE 
iii
SEX, DRUGS, AND RODENT REWARD: AN EXPLORATION OF THE SEX-
SPECIFIC ROLES OF NICOTINIC ACETYLCHOLINE RECEPTORS IN ETHANOL 
REWARD 
A Dissertation Presented  
By  
Melissa Guildford Derner  
This work was undertaken in the Graduate School of Biomedical Sciences 
Neuroscience 
The signature of the Thesis Advisor signifies  
validation of Dissertation content  
Andrew R. Tapper, PhD, Thesis Advisor  
The signatures of the Dissertation Defense Committee signify completion and approval 
as to style and content of the Dissertation 
José Lemos, PhD, Member of Committee  
Gilles Martin, PhD, Member of Committee  
David Weaver, PhD, Member of Committee  
David Moorman, PhD, External Member of Committee  
The signature of the Chair of the Committee signifies that the written dissertation meets 
the requirements of the Dissertation Committee 
Michael Francis, PhD, Chair of Committee  
The signature of the Dean of the Graduate School of Biomedical Sciences signifies that 
the student has met all graduation requirements of the School.  
Anthony Carruthers, PhD 
Dean of the Graduate School of Biomedical Sciences  
December 8, 2016 
!iv
 DEDICATION & ACKNOWLEDGEMENTS 
 Graduate school, much like life itself, is more a journey than a destination. On the 
road to a PhD, sometimes you are on the autobahn, and sometimes you’re anywhere near 
Boston during rush hour. Whatever the speed, you are not alone on your journey, though 
sometimes it may feel that way.  Even the strongest, most efficient engine in the world 
could not move an inch without help.  
 On my journey, I picture myself as the engine. Chugging along, working to get 
this road traversed, a little worse for wear but still running. I have my inspection sticker 
TRAC committee, making sure everything is running smoothly each year of my journey, 
and my lovely lab mates are my radio - making the time fly by, laughing, chatting, 
commiserating, advising. Paul is the fuzzy dice hanging from the mirror, reminding me 
not to take myself too seriously, and Andrew is the turbo boost, ready to light a fire under 
your tailpipe if you are moving too slowly. He’s also the GPS, giving (mostly) accurate 
directions, letting me know when I need to make a U-turn, and reminding me how much 
longer until I reach my destination.  
 I’ve certainly encountered people on my journey who have been fender benders - 
people that I have followed in error, and not paid attention enough to see that they’ve 
stopped. These accidents aren’t fun, but they make you realize they are sitting still while 
you are moving, and make you change course. Fortunately, I’ve have been so lucky to 
!v
have great friends as the fuel in my tank when I was just about running on fumes, or 
spare tires that, despite not being used often, I knew were always there if I was stuck.  
 I’ve had grandparents, some here and some above, as my mirrors, making sure 
that I am always looking out for those around me, and that I remember where I came 
from. My in-laws are my windshield wipers, helping me see clearly no matter the 
weather.  
 My brother is the random drive to nowhere, the unplanned pit stops, reminding 
me that the journey isn’t just about getting there, it’s about the experiences along the way. 
My father is the open windows, reminding me to listen to the sounds, feel the air, and 
enjoy the simplicity of nature. My step-father is my jumper cables, my tire iron, and my 
owner’s manual, always ensuring I feel safe, strong, and empowered, no matter the 
situation. My mom, my headlights, has always been there to illuminate my path and help 
me navigate in the dark.  
 My husband Jason is my chassis; he holds all of the pieces together and makes the 
journey possible. He is the unsung hero, the behind-the-scenes support system. Without a 
chassis, the engine can run it’s heart out and still will not be able to go anywhere. I am 
where I am because of his unending support.  
 My son, Henry, is the sunshine on my arm on a warm, breezy, summer day’s 
drive. He’s the wind in my hair, the smell of rain, and my favorite song on the radio. He 
!vi
is the one day a year I actually get down route 9 without hitting all red lights, and the 
peak of fall foliage. He makes the whole journey worthwhile.  
 This is dedicated to everyone who has encouraged, supported, guided, and loved 
me along this crazy, winding road. You are all the reason I was able to make it to my 
destination. This debt is not one I can pay back, much like my student loans, but I will 
certainly try. Thank you, from the bottom of my heart. 
!vii
ABSTRACT 
 Alcohol, recently named the most dangerous drug in the world, contributes to 
nearly 40% of violent crimes and fatal traffic accidents, increases risk of roughly 60 
different diseases and injuries, and is responsible for 2.5 million deaths each year 
worldwide. Despite these staggering figures, treatments remain ineffective and riddled 
with adverse side effects, making successful use of even the most effective treatments 
unlikely. Moreover, many of the treatments, and the supporting research, have focused 
only on male subjects, despite sex differences in various alcohol-related behaviors.  
 Human alcohol use is frequently accompanied by nicotine use, and vice versa, 
suggesting a common mechanism of the two drugs. In fact, alcohol may act through the 
same family of receptors as nicotine, the nicotinic acetylcholine receptors (nAChRs), 
eliciting similar activation of the reward pathway as nicotine and other drugs of abuse. 
Studies have shown that nAChRs containing the α4 and/or α6 subunits are involved in 
nicotine-induced activation of the reward pathway, leading to the hypothesis that these 
same receptor subtypes may be important for alcohol effects in the brain as well.  
 Using male and female genetic mouse models and various behavioral assays, we 
have shown not only that these α4 and/or α6-containing nAChRs are involved in alcohol-
related behaviors and activation of the reward pathway, but also show sex differences in 
this involvement. Uncovering the mechanism of alcohol in the brain, in males as well as 
in females, is an important step in developing targeted treatments for alcohol abuse. 
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CHAPTER I: Introduction 
Addiction  
 The definition of addiction given depends on to whom the question is directed. A 
quick internet search will declare that addiction is “the fact or condition of being addicted 
to a particular substance, thing, or activity,” with synonyms including habit and problem 
(google.com). The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) no 
longer lists drug addiction as a diagnosable condition, instead classifying it as a severe 
form of an abuse disorder (Hasin, O'Brien et al. 2013). According to the National Institute 
on Drug Abuse (NIDA 2014), drug addiction is a “chronic, relapsing brain disease that is 
characterized by compulsive drug seeking and use, despite harmful consequences.” With 
the general population, psychologists, and scientists all having very different definitions 
of the same condition, it is no wonder that, despite nearly 22.7 million Americans in need 
of treatment for illicit drug or alcohol use, only about 11% of those ever receive treatment 
(SAMHSA 2014), and even fewer are able to remain abstinent.  
 In humans, addiction happens in stages. The initiation phase, also known as binge 
or intoxication (Becker and Koob 2016), is characterized by use of the drug for its feel-
good, or rewarding, properties. This use is considered goal-directed (Barker, Torregrossa 
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et al. 2010), with the goal being the associated euphoria. Most people will not progress 
beyond this casual use (NIDA 2014); those that escalate their use, in quantity or 
frequency or both, may eventually lose control of their drug use (Neasta, Ben Hamida et 
al. 2010) and qualify as abusers. This hazardous use of the drug of choice can change the 
brain itself, in structure and/or function (NIDA 2014), and can transition into habitual use 
(Barker, Torregrossa et al. 2010). What was once euphoria-driven is now habit, driven not 
by the positive outcome once associated with the drug, but by a preoccupation with and 
habitual use of the drug (Barker, Torregrossa et al. 2010, Becker and Koob 2016). It is at 
this point that the drug use is considered compulsive versus impulsive (Hommer, Bjork et 
al. 2011) - physically reliant on the drug not necessarily for euphoria but for normalcy - a 
hallmark of dependence.  
 One of the lingering questions in addiction research is why some end up addicted 
while others can use casually, or even abuse the drug, without becoming physically 
dependent. There are many circumstances that can predispose someone to addiction, 
many of which are governed by an increased likelihood of first use, including education, 
socioeconomic status, and geographic location, but there are also genetic factors that can 
influence the transition from use to abuse, including biological sex (SAMHSA 2014).  
 Biological sex begins with conception, where an egg containing an X ‘sex’ 
chromosome is fertilized by a sperm cell containing either an X or the male-defining Y 
chromosome. During development, this chromosomal sex is complimented by gonadal 
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sex, which relies on the presence or absence of sex hormones, especially testosterone 
((Barker, Torregrossa et al. 2010).  The chromosomal sex influences the gonadal sex, in 
that the testes defining Sry gene, located on the Y chromosome, initiates formation of the 
testes and thus production of testosterone (Barker, Torregrossa et al. 2010) although there 
are instances wherein a developmental issue can cause a disconnect between the two, 
leading to chromosomal males with female attributes due to a lack of testosterone, for 
example, which further complicates the role of biological sex in the development of 
addiction.  
 Due to the dependent nature of the chromosomal and gonadal sex, with the testes 
gene present on the male-specific Y chromosome, it can be difficult to determine the 
function and/or role of each in addiction, for example. However, by physically separating 
the two in a four core genotype mouse model, Barker et al. (2010)  were able to explore 
each independently of the other. They deleted the Sry gene from the Y chromosome and 
reintroduced it onto an autosome, a chromosome present in both sexes. This allowed the 
testes-forming gene to sort independently of the sex chromosome, allowing for four 
genotypes: XX female, XX male, XY female, and XY male, where the sex chromosomes 
are listed followed by the gonadal sex as determined by the presence or absence of the 
Sry gene (Barker, Torregrossa et al. 2010).  
 Without the ability to disentangle the various effects of biological sex in humans, 
observations must be assessed with any number of influencing factors in mind. Human 
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males are more likely to use drugs, though women proceed from use to abuse and 
dependency more quickly than their male counterparts (Becker and Hu 2008, Barker, 
Torregrossa et al. 2010, Lenz, Muller et al. 2012, Agabio, Campesi et al. 2016, Becker 
and Koob 2016), and enter into treatment more rapidly (Carroll and Lynch 2016). In both 
males and females, the biggest issue in determining who will become addicted is finding 
the potential drug abuser before they even use the drug. However, most studies done on 
drug addiction have been conducted using only male subjects, which, given the 
differences in the addiction cycle timeline between males and females, is unlikely to 
translate as well in female addicts. To further complicate the study of sex and addiction, 
there are different types of behavioral sex differences that lead to the different phenotypes 
in each sex. For example, quantitative differences, where the same behavioral response 
occurs with a difference in the magnitude of the response, is fairly easily observed, as is a 
population difference, wherein more of one sex show a given response than another. 
However, if the behavior is completely different, a qualitative difference, or identical 
superficially but due to a completely different mechanism, the interpretation becomes less 
clear (Becker and Koob 2016).  
 Sex differences exist not only at the behavioral level, but at the neuronal level. It 
has been shown, in humans as well as rodents, that sexually dimorphic regions exist and 
may play a role in the differential effects of drugs in each sex (Retson, Reyes et al. 2015). 
Two of the main pathways involved in drug addiction are the so-called reward and  anti-
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reward pathways (Koob and Le Moal 2008), and each has shown sex differences, whether 
at baseline  (Bobzean, DeNobrega et al. 2014) or in response to drugs of abuse (Retson, 
Reyes et al. 2015), respectively. This dissertation will focus on the reward pathway - the 
entry point into the addiction cycle.   
Reward  
 There are several hypotheses regarding the risk of addiction, though it is uncertain 
how accurate they are, or if they can be used across the various stages of addiction. Many 
of these theories pertain to the very beginning of the addiction cycle during the binge/
intoxication stage and detail the way in which reward is processed in the brain. A reward 
is something that possesses hedonic value in addition to being a positive reinforcer; it 
increases the likelihood of an operant response (Becker and Koob 2016). There are 
various natural rewards, including food, sex, and social interaction, and there are also less 
natural sources of reward including gambling and drugs of abuse.  
 Molecularly, reward is the result of activation of the mesocorticolimbic dopamine 
‘reward’ pathway in the brain (Good and Lupica 2009, Tsai, Zhang et al. 2009) and the 
subsequent increased release of dopamine in the nucleus accumbens (NAc), the 
quintessential reward area.  The three main areas involved in the reward pathway are the 
prefrontal cortex (PFC), the ventral tegmental area (VTA) and the NAc (Figure 2). The 
PFC sends glutamatergic projections to the VTA, and receives reciprocal dopaminergic 
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(DAergic), glutamatergic, and projections containing gamma-aminobutyric acid (GABA) 
(Fields, Hjelmstad et al. 2007). The VTA itself is comprised of dopaminergic projection 
neurons as well as GABAergic projection and interneurons. These inhibitory GABAergic 
interneurons synapse onto DAergic neurons within the VTA, and thus influence 
activation of  NAc-projecting DA neurons as well. In addition to the DA projection, the 
VTA also supplies glutamate, co-released by DA neurons, as well as GABA, to the NAc, 
which sends GABAergic projections back to the VTA. Although the pathway in its 
entirety is vast and complex, with many very specific, discrete connections and many 
levels of modulatory input, the activity of the DA projection from the VTA to the NAc is 
ultimately the end result.  
 Dopaminergic neurons projecting from the VTA provide tonic DAergic input to 
the NAc under normal conditions, firing at about 1Hz, and switch to burst or phasic firing 
with a much higher firing rate upon activation (Good and Lupica 2009, Tsai, Zhang et al. 
2009, Liu, Zhao-Shea et al. 2012, Liu, Hendrickson et al. 2013); this switch from tonic to 
phasic is characteristic of reward, representing the increased dopamine being released in 
the NAc (Pidoplichko, DeBiasi et al. 1997, Rodd, Melendez et al. 2004, Okamoto, 
Harnett et al. 2006, Good and Lupica 2009, Hendrickson, Guildford et al. 2013).  
 All known drugs of abuse act through this pathway, and result in a much more 
robust activation than natural rewards. As such, once drug reward is experienced it tends 
to be preferred over natural rewards, a critical step in the development of addiction 
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(Hommer, Bjork et al. 2011). The reward deficiency syndrome (RDS) hypothesis of 
addiction formation proposes that addicts, or those predisposed to addiction, have a less 
active reward pathway than their non-addict peers, which is not sufficiently activated by 
natural rewards such as food, sex, or social interaction. If someone with RDS uses a drug, 
this drug will be marked as especially salient and prioritized over the ineffective natural 
rewards (Hommer, Bjork et al. 2011). This and other addiction hypotheses highlight the 
importance of the binge/intoxication, goal-directed phase of drug use in the development 
of addiction, but, in order to test these hypotheses, high-risk, drug-naive human subjects 
that then go on to develop an addiction, would be needed.  
 Given the inability to decipher deficiencies or dysfunctions that preceded drug use 
from those resulting from drug use in human addicts, various animal models have been 
employed in order to uncover the mechanism underlying the development of a drug 
addiction. A multi-faceted approach is used, investigating the molecular and behavioral 
effects of the drug, as well as what happens when the drug is subsequently removed. With 
many of the hypotheses surrounding the development of addiction referencing reward 
system dysfunction, this is where much of the drug addiction research to date has been 
focused. Behaviorally, there are many assays used to investigate the various stages of 
drug addiction. For the intoxication stage, conditioned place preference can be used to 
assay reward. In this classical conditioning paradigm, the animal is given the drug in one 
chamber, and vehicle in another. Subsequent preference for the chamber associated with 
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the drug, in the absence of the drug itself, suggests reward (Gibb, Jeanblanc et al. 2011). 
Another common assay is operant self-administration, which looks at the tendency to 
self-administer a drug once the drug is associated with the resultant euphoria or reward. 
This assay can then be employed in other stages, including maintenance and craving, 
where the animal is forced to perform a task many times before receiving the drug. The 
more they are willing to do for each dose, the stronger their motivation is for the drug.  
Alcohol 
 Not all drugs of abuse are the illicit, illegal substances that come to mind when 
discussing addiction. In fact, alcohol has been labeled the most dangerous drug in the 
world, being involved in nearly 40% of violent crimes, fatal traffic accidents, and other 
punishable offenses (Greenfeld and Henneberg 2001). As indicated in the involvement in 
violent and even deadly encounters, alcohol's effects extend beyond the drinker to those 
around them and to society as a whole (WHO 2015).  Drunk driving, violence, child 
neglect or abuse, decreased productivity, increased medical costs, all in addition to the 
increased incidence of cancers, liver cirrhosis, and roughly 60 other diseases and types of 
injures experienced by the drinker, makes alcohol an especially troublesome drug of 
abuse (WHO 2015).  Alcohol is involved in nearly 2.5 million deaths per year, 
responsible for roughly 4% of all deaths worldwide, and is the third leading risk factor for 
preventable injury (McGinnis and Foege 1993, WHO 2015).  The greatest risk of alcohol-
related issues belongs to those in middle-income, developed countries, especially males, 
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for whom alcohol is responsible for 6.2% of all deaths, versus 1.1% for females (WHO 
2015).  Despite all of this, alcohol continues to be not only widely available and easily 
accessible, but also socially acceptable and legal.   
 With almost 90% of people in the United States having reported use of alcohol in 
their lifetime, and over 70% within the past year, alcohol is the most used drug of abuse 
(SAMHSA 2014). Not all alcohol use is harmful, and moderate use has even been shown 
to be beneficial, decreasing the risk of ischemic heart disease, stroke, and diabetes 
(Millen, Abrams et al. 2016). This moderate consumption, defined as up to 1 drink per 
day for women, 2 for men, is not the type of harmful drinking that typically leads to 
alcohol dependence (Millen, Abrams et al. 2016). Unlike moderate consumption, harmful 
drinking is sometimes referred to as heavy episodic or binge drinking, and is defined as 
drinking at least 60g of pure alcohol on at least once occasion in the past week with the 
intent of becoming intoxicated (WHO 2015), or four drinks in two hours for a female, 
five for a male (Coon, Piasecki et al. 2014).  Over 11% of drinkers experience these 
binges weekly, and it is the volume and pattern of consumption which makes the 
frequency of binge drinking and resulting intoxication the behavior most associated with 
alcohol dependence (Kendler, Gardner et al. 2014). Males tend to binge drink more 
frequently than females, and also have higher rates of alcohol abuse, although the gap is 
closing quickly (Becker and Koob 2016).  
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 Despite higher frequency of binge drinking and abuse in males, females proceed 
more quickly from alcohol use to abuse than their male counterparts, and are more 
vulnerable to its negative effects (Becker and Hu 2008, Barker, Torregrossa et al. 2010, 
Lenz, Muller et al. 2012, Agabio, Campesi et al. 2016, Becker and Koob 2016). 
Additionally males, when given the same dose of alcohol as females, experience double 
the dopamine increase in the NAc (Lenz, Muller et al. 2012), while females develop a 
higher blood ethanol concentration, more motor impairment, and increased sedation 
(Agabio, Campesi et al. 2016). Some of the differences involve the way in which each 
sex interacts with their environment, including the different opportunities, and the way in 
which each sex is viewed in terms of consequences of excessive drinking (Sanchis-
Segura and Becker 2016); these differences may also be influenced by the reasons behind 
why each  drinks, with women more likely to drink in response to negative emotions and 
men drinking to enhance positive (Becker and Koob 2016), but there are certainly genetic 
components as well.  
 Animal studies have uncovered sex differences in alcohol consumption and 
related behaviors, implying that not all differences seen between human men and women 
can be accounted for via outside influences. Specifically, female mice tend to drink more 
than males, and unlike humans, male mice will experience greater withdrawal symptoms 
than will their female counterparts (Barker, Torregrossa et al. 2010, Becker and Koob 
2016). Some alcohol-related behaviors have been studied using the four core genotype 
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mouse model, which allows a dissection of chromosomal and gonadal sex effects, and 
show differential results depending on the specific behavior. Alcohol intake, for instance, 
is predicted by gonadal sex independent of chromosomal sex, with males consuming 
more than females, whereas habitual responding for alcohol depends mainly on the 
chromosomal sex, with XY switching from goal-directed to habitual responding faster 
than XX (Barker, Torregrossa et al. 2010). This switch, representing the progression from 
casual use into the addiction cycle, also reflects a transition from the ventral striatal 
reward pathway into the dorsolateral striatal areas (Barker, Torregrossa et al. 2010) and 
suggests sex differences in the formation of addiction may involve the transition out of 
this reward-driven intoxication/binge stage.  
  
Dopamine 
 As previously mentioned, all drugs of abuse activate the reward pathway, 
specifically causing an increase in DA release in the NAc, which is a hallmark of drug 
reward. Increased NAc DA following alcohol has been shown via micro-dialysis in 
animals (Gremel and Cunningham 2008, Burkhardt and Adermark 2014). In humans, this 
presumed increase in DA release correlates with self-reported euphoria following alcohol 
(Soderpalm and Ericson 2013).  Once released in the NAc, the DA binds to various 
DAergic receptors, causing the downstream drug-related behaviors. If these receptors are 
unavailable, either antagonized, knocked out, or knocked down, alcohol consumption 
decreases, alcohol-induced psychomotor stimulation is reduced, and alcohol reward is 
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attenuated (Bahi and Dreyer 2012, Soderpalm and Ericson 2013). A genetic variation in 
the D1 subtype dopamine receptor (D1R) can affect alcohol consumption in non-human 
primates, and levels of NAc DA are decreased in alcohol-preferring mice versus non-
preferring, as well as in human alcoholics versus non-alcoholics (Bahi and Dreyer 2012, 
Soderpalm and Ericson 2013, West, Boss-Williams et al. 2015). In humans, this may 
predispose abusers to addiction, but it may also be a result of chronic, high-dose alcohol 
consumption, which has been shown to reduce the number of D1Rs in rodent midbrain 
and to decrease DA to below the baseline (Ericson, Molander et al. 2003, Bahi and 
Dreyer 2012, Soderpalm and Ericson 2013).  
 The increase in DA following alcohol is due to an increase in activation and/or  
firing rate of DAergic neurons in the VTA that project to the NAc, which has been shown 
following a dose of alcohol that elicits a reward response in rodents (Doyon, York et al. 
2003, Ericson, Molander et al. 2003, Gremel and Cunningham 2008, Hendrickson, Zhao-
Shea et al. 2009, Adermark, Clarke et al. 2011, Liu, Hendrickson et al. 2013, Soderpalm 
and Ericson 2013, Burkhardt and Adermark 2014, Schilaty, Hedges et al. 2014, West, 
Boss-Williams et al. 2015),  but the way in which it activates this pathway remains 
unknown. Although there is some evidence of direct activation of DAergic neurons via 
ethanol (Burkhardt and Adermark 2014), most studies agree that the activation is more 
likely indirect, with ethanol potentiating the response to some other transmitter such as 
serotonin (Jerlhag, Grotli et al. 2006, Morikawa and Morrisett 2010, Soderpalm and 
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Ericson 2013)  or acetylcholine (Marszalec, Aistrup et al. 1999, Liu, Zhao-Shea et al. 
2013, Soderpalm and Ericson 2013, Burkhardt and Adermark 2014). Infusion of ethanol 
directly into the VTA of rodents leads to an increase in both serotonin and DA, as does 
inhibition of serotonin reuptake, and serotonergic agonists potentiate the DA increase in 
response to ethanol (Morikawa and Morrisett 2010). Serotonergic antagonists have the 
opposite effect, blocking the alcohol-induced increase in NAc DA (Jerlhag, Grotli et al. 
2006). With serotonergic receptors present on VTA DA terminals, it is likely that alcohol 
acts directly on them, making serotonergic antidepressents, specifically specific serotonin 
reuptake inhibitors (SSRIs), potentially viable for treatment of alcohol use disorders 
(Jerlhag, Grotli et al. 2006, Morikawa and Morrisett 2010). Acetylcholine (ACh) 
may also be involved in the alcohol-induced increase in NAc DA, with alcohol unable to 
increase the firing rate of these DA neurons in the absence of ACh (Marszalec, Aistrup et 
al. 1999, Liu, Zhao-Shea et al. 2013, Soderpalm and Ericson 2013, Burkhardt and 
Adermark 2014). Additionally, alcohol has been shown to increase ACh levels in the VTA 
in parallel with the increased DA in the NAc, suggesting a potential causal relationship 
(Ericson, Molander et al. 2003, Soderpalm and Ericson 2013).  Similarly to serotonin 
receptors, antagonists of ACh receptors block various alcohol-related molecular and 
behavioral outcomes, further suggesting a role for ACh.  
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Acetylcholine and Nicotinic Acetylcholine Receptors  
 The involvement of ACh in the activation of the reward pathway following 
alcohol administration is supported by studies showing that mecamylamine, a non-
selective antagonist for one class of cholinergic receptors, blocks alcohol-induced 
activation of the VTA, the resulting increase in NAc  DA, and blocks various alcohol-
related behaviors in rodents (Hendrickson, Zhao-Shea et al. 2009, Burkhardt and 
Adermark 2014). The receptors involved, according to the mecamylamine data, are 
nicotinic acetylcholine receptors (nAChRs), which are located not only in the reward 
pathway and much of the rest of the brain, but are also on DA and GABA neurons within 
the VTA (Bowers, McClure-Begley et al. 2005, Morikawa and Morrisett 2010, 
Hendrickson, Guildford et al. 2013, Schilaty, Hedges et al. 2014, Ngolab, Liu et al. 
2015). As the name implies, these receptors are targets of nicotine, the addictive 
compound in tobacco. These ligand gated cation channels are activated not only be 
exogenous nicotine, but by endogenous ACh as well. Once ligand is bound, the receptor 
is activated, and the channel opens, allowing Na+ and Ca2+ to move into the cell along 
their gradient. The receptor can also exist in two other states: closed, when the receptor is 
at rest, and desensitized, when the receptor is unresponsive to ligand (Dani and Bertrand 
2007). The channel itself is formed by the second of five transmembrane domains in each 
of five subunits, making the receptor pentameric. The five subunits can be identical, 
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(homomeric), or can contain a mixture of α and β subunits (heteromeric). Currently, there 
are twelve known neuronal nAChR subtypes, α2-10 and β2-4. High affinity receptors are 
heteromeric, and the most ubiquitous of these is the α4β2-containing (α4β2*, where the * 
indicates the possible presence of other subunits) (Dani and Bertrand 2007). Homomeric 
receptors, made only of α subunits, are lower affinity, and generally are formed by α7, α9, 
and α10 (Dani and Bertrand 2007).  The subunits included in the nAChR are referred to 
as the nAChR subtype, and the subtypes each have their own pharmacological and 
biophysical properties. (Figure 1.1)   
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Figure 1.1 Neuronal nAChR Structure.  A.  Membrane topology of a neuronal nAChR 
subunit.  Each nAChR subunit contains four transmembrane domains (M1-M4), an 
extracellular amino- and carboxy-terminus, and a prominent M3-M4 intracellular loop of 
variable length.  B.  Five subunits coassemble to form a functional subunit.  C. 
Homomeric receptors consist of α subunits only and usually have low affinity for agonist. 
To date, only mammalian α7, α9, and α10 (not shown) subunits may form functional 
homomers. D.  The majority of high affinity nAChRs are heteromeric and consist of a 
combination of α and β subunits.  Importantly, multiple α subunits have been shown to 
coassemble with multiple β subunits in the pentameric nAChR complex (illustrated here 
by α4α6β3β2).  ACh binding sites are depicted as red triangles. From (Hendrickson, 
Guildford et al. 2013) 
  
 The potential overlapping of alcohol and nicotine targets is not unexpected, as 
nicotine and alcohol are the most co-abused drugs, with nearly 90% of alcoholics also 
being addicted to nicotine, and 60-80% of smokers identifying as alcoholics as well 
(Bowers, McClure-Begley et al. 2005, Jerlhag, Grotli et al. 2006, Kuzmin, Jerlhag et al. 
2009, Lajtha and Sershen 2010, Chatterjee, Steensland et al. 2011, Hendrickson, 
Guildford et al. 2013). Addiction to each of the two drugs is a risk factor for the other, 
and although this could be due to the same population being vulnerable to any type of 
reward or drug of abuse, there could also be an interaction of the drugs or a genetic 
predisposition to both (Kamens, McKinnon et al. 2009, Lajtha and Sershen 2010, 
Kamens, Hoft et al. 2012).  
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Nicotine and Alcohol Interactions  
 Table 1.1 and the following text excerpt are from and article previously published in:  
Hendrickson, L.M., M.J. Guildford, and A.R. Tapper, Neuronal nicotinic acetylcholine 
receptors: common molecular substrates of nicotine and alcohol dependence. Front 
Psychiatry, 2013. 4: p. 1-16. doi: 10.3389/fpsyt.2013.00029. 
 Human studies have shown that individuals dependent on alcohol have higher 
rates of nicotine dependence (Hughes 1996, Room 2004), and smokers tend to consume 
more ethanol than non-smoking alcohol users (York and Hirsch 1995). Unlike the 
majority of clinical studies, nicotine administration can either increase ethanol intake 
(Potthoff, Ellison et al. 1983, Blomqvist, Ericson et al. 1996, Smith, Horan et al. 1999, 
Le, Corrigall et al. 2000, Clark, Lindgren et al. 2001, Ericson, Molander et al. 2003), or 
decrease ethanol intake (Nadal, Chappell et al. 1998, Dyr, Koros et al. 1999, Sharpe and 
Samson 2002) in rats (Table 1.1). These conflicting results have led to a complex and 
interesting questions: under what conditions (i.e. time delay between nicotine and 
ethanol, dose of nicotine, length of ethanol presentation, acute versus chronic nicotine/
ethanol etc.) does nicotine increase ethanol intake, and what conditions cause a decrease 
in ethanol intake?  
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Table 1.1  Neuronal nAChR ligands that modulate alcohol behaviors 
!20
 
Blomqvist et al. demonstrated that daily nicotine during ethanol deprivation and 
ethanol reinstatement increases ethanol intake and preference in rats shown to have a 
medium baseline preference (25-65%) for ethanol over water (Blomqvist, Ericson et al. 
1996).  Similarly, Le et. al. demonstrated that rats increased lever presses for ethanol 
during the course of daily nicotine injection paired 15 min prior to an operant session (Le, 
Wang et al. 2003).  These data are in agreement with various other experiments in which 
nicotine was given either constantly or repeatedly (Potthoff, Ellison et al. 1983, Smith, 
Horan et al. 1999, Ericson, Engel et al. 2000, Olausson, Ericson et al. 2001).  In rats, 
nicotine can also reinstate alcohol seeking after extinction and increase ethanol self-
administration when administered during an ethanol deprivation period (Lopez-Moreno, 
Trigo-Diaz et al. 2004).  Interestingly, rats given nicotine only during the relapse period, 
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once self-administration has resumed after a deprivation period, consume less ethanol, 
and rats given nicotine during both abstinence and relapse increased ethanol intake 
compared to control (Alen, Gomez et al. 2009). 
In contrast, Sharpe and Samson (2002) demonstrated that ethanol intake and lever 
pressing during operant ethanol self-administration are both decreased after a high dose 
of nicotine (0.7 mg/kg, subcutaneous injection (s.c.), expressed as free base nicotine) 30 
minutes prior to ethanol self-administration, and with a lower dose of nicotine (0.35 mg/
kg, s.c.).  While locomotor depression by nicotine could potentially confound the 
interpretation of decreased ethanol self-administration, this is unlikely as nicotine 
injections did not decrease sucrose self-administration.  Thus, Sharpe and Samson 
propose that nicotine could be acting as a reinforcer of ethanol, decreasing the amount of 
ethanol necessary to achieve satiety (Sharpe and Samson 2002). This is in agreement with 
other studies in which nicotine is administered either immediately prior to, or within 30 
minutes of, ethanol presentation or self-administration (Nadal, Chappell et al. 1998, 
Damaj 2001).   
To reconcile differences in nicotine effects on ethanol consumption and self-
administration, Hauser et al. demonstrated that acute nicotine administration affects 
ethanol seeking and relapse in a time-dependent manner. Nicotine injection immediately 
prior to an ethanol operant self-administration session in ethanol preferring female rats 
elicits reduced responding for ethanol compared to a saline injection, whereas nicotine 
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exposure 4 hrs prior will increase responses (Hauser, Getachew et al. 2012). These data 
indicate that acute nicotine may initially act as a substitute for ethanol at the immediate 
time-point causing a reduction in craving for ethanol and, at the later time-point, nicotine 
may lead to desensitization of nAChRs in the brain, enhancing ethanol seeking.    
As in rats, acute nicotine immediately prior to presentation of ethanol in the DID 
paradigm reduces consumption in mice (Hendrickson, Zhao-Shea et al. 2009), whereas 
chronic nicotine treatment increases consumption (Sajja and Rahman 2012).  The 
reduction of ethanol consumption is mediated by nAChRs containing the α4 subunit: 
nicotine fails to reduce consumption in α4 KO mice; whereas acute sub-threshold 
nicotine doses are sufficient to reduce consumption in Leu9′Ala mice (Hendrickson, 
Gardner et al. 2011).  Acute nicotine activates the posterior VTA as measured by 
increased c-Fos in mouse VTA DAergic neurons while co-injection of ethanol does not 
further activate these neurons, consistent with nicotine substituting for ethanol during this 
treatment schedule (Hendrickson, Zhao-Shea et al. 2009).   
The mechanistic basis of chronic nicotine on ethanol consumption is unclear. 
However, nicotine potentiates the response to ethanol in VTA DAergic neurons in male 
and female rodents (Clark and Little 2004, Ding, Katner et al. 2012). These data indicate 
that chronic nicotine treatment may actually increase the reinforcing/rewarding properties 
of alcohol.  
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nAChR Subtypes Involved in Alcohol Behaviors 
 Figure 1.2 and the following text excerpt are from an article previously published in:  
Hendrickson, L.M., M.J. Guildford, and A.R. Tapper, Neuronal nicotinic acetylcholine 
receptors: common molecular substrates of nicotine and alcohol dependence. Front 
Psychiatry, 2013. 4: p. 1-16. doi: 10.3389/fpsyt.2013.00029. 
 Studies in VTA responses to nicotine indicate that DAergic neurons contain 
several nAChR subtypes including α4β2*, α4α5β2*, α4α6β2*, α6β2*, α3β2*, and α7 
(Picciotto, Zoli et al. 1998, Champtiaux, Han et al. 2002, Marubio, Gardier et al. 2003, 
Grady, Salminen et al. 2007, Gotti, Guiducci et al. 2010, Zhao-Shea, Liu et al. 2011, Liu, 
Zhao-Shea et al. 2012) (Figure 1.2).  Identifying the precise subunit composition of 
nAChRs involved in ethanol consumption and activation of VTA DAergic neurons is 
challenging due to the sheer number of potential subunit combinations that may be 
expressed in the VTA.  However, identifying one or more nAChR subtypes involved in 
ethanol activation of VTA and/or reward may lead to novel targets to reduce 
consumption.   
 Systemic injection or VTA infusion of the competitive α4β2* nAChR antagonist, 
dihydro-β-erythroidine (DHβE), in rats, fails to reduce ethanol-mediated DA release in 
the NAc and ethanol intake (Ericson, Molander et al. 2003, Chatterjee, Steensland et al. 
2011).   In addition, low doses of DHβE also have little effect on operant responding for 
ethanol in rats, although a higher dose can reduce responding (Kuzmin, Jerlhag et al. 
2009).  Systemic injection of DHβE does not reduce consumption in mice as measured in 
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the DID assay nor ethanol-induced NAc DA release (Larsson, Svensson et al. 2002, 
Hendrickson, Zhao-Shea et al. 2009).  Together these data suggest that α4β2* nAChRs 
may not be critical for ethanol reward and consumption behavior.  However, sensitivity of 
α4β2* nAChR blockade by DHβE is dependent on the stoichiometry of the receptor and 
the expression of other non-α4β2 subunits that may also be present in an α4β2* nAChR 
complex (Harvey and Luetje 1996, Harvey, Maddox et al. 1996, Le, Corrigall et al. 2000, 
Larsson, Svensson et al. 2002, Ericson, Molander et al. 2003, Moroni, Zwart et al. 2006, 
Lof, Olausson et al. 2007, Kamens and Phillips 2008).   
 The α7 selective antagonist, methyllycaconitine (MLA), does not affect ethanol-
mediated behaviors including consumption, ethanol-induced DA release in NAc and 
ethanol operant responding in rats, or consumption in mice (Larsson, Svensson et al. 
2002, Hendrickson, Zhao-Shea et al. 2009, Kuzmin, Jerlhag et al. 2009).  While caution 
with interpretation of these results is warranted due to data indicating higher 
concentrations of MLA may also antagonize non-α7 nAChRs (of an unknown nAChR 
subtype that may include α6 and/or α3 subunits (Mogg, Whiteaker et al. 2002)), 
homomeric α7 nAChRs may not be involved in ethanol reinforcement (Larsson, 
Svensson et al. 2002, Hendrickson, Zhao-Shea et al. 2009, Kuzmin, Jerlhag et al. 2009).   
 On the other hand, the α3β2*, β3*, and α6* subtype-selective antagonist, α-
conotoxin MII (Cartier, Yoshikami et al. 1996), when infused into the VTA does inhibit 
ethanol consumption, operant responding, and DA release in the NAc of rats (Larsson, 
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Jerlhag et al. 2004, Larsson, Edstrom et al. 2005, Kuzmin, Jerlhag et al. 2009)  and 
reduce ethanol-induced locomotor stimulation and increases in NAc DA release in mice 
(Larsson, Jerlhag et al. 2004, Jerlhag, Grotli et al. 2006).  Importantly, approximately half 
of α-conotoxin MII-sensitive nAChRs in the striatum also contain the α4 subunit (Grady, 
Salminen et al. 2007, Salminen, Drapeau et al. 2007) and deletion of β2* nAChRs nearly 
abolishes α-conotoxin MII binding in the VTA (Marubio, Gardier et al. 2003).  However, 
infusion of α-conotoxin PIA, a version of the toxin which may have more selectivity for 
α6* nAChRs than α3* nAChRs (Dowell, Olivera et al. 2003), failed to reduce ethanol 
induced DA release in NAc when infused in the VTA suggesting that α3* nAChRs may 
be more critical for ethanol reward (Jerlhag, Grotli et al. 2006).  Finally, systemic 
injection of the α3β4* nAChR selective antagonist 18-methoxycoranaridine (18-MC) 
reduces ethanol consumption in alcohol-preferring rats (Rezvani, Overstreet et al. 1997). 
However, direct infusion of 18-MC into the VTA fails to reduce alcohol consumption 
(Carnicella, He et al. 2010) in rats consistent with data indicating low expression of β4* 
nAChRs in VTA DAergic neurons (Gotti, Guiducci et al. 2010, Zhao-Shea, Liu et al. 
2011).   
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Figure 1.2 Neuronal nAChR expression in the reward pathway.  A.  Sagittal rodent 
section illustrating the simplified mesocorticolimbic and habenulo-peduncular circuitry. 
Known neuronal nAChR subtypes expressed in different nuclei are indicated (for a 
review see (Millar and Gotti 2009)).  B. In the VTA, alcohol stimulates DAergic neurons 
at least, in part, via nAChR activation.  Ethanol increases ACh release (red arrow, 
presumably through cholinergic projection from the LDT/PPTg) which in turn activates 
nAChRs on DAergic neurons driving activity.  In addition, ethanol potentiates ACh 
activation at high affinity α4β2* nAChRs (red plus sign).  The effect of alcohol on 
additional nAChRs in the VTA is unknown. This confluence of events in combination 
with other effect of alcohol in the VTA ultimately increases DA release in NAc (red 
arrow). Ventral tegmental area (VTA); Nucleus accumbens (NAc); Prefrontal cortex 
(PFC); Lateral habenula (LH); Medial habenula (MH); Interpeduncular nucleus (IPN), 
Lateral dorsal tegmentum (LDT); Pedunculopontine tegmentum (PPTg). (Hendrickson, 
Guildford et al. 2013) 
Thesis Overview  
 Given the unclear pharmacological data, the following chapters approach the 
mechanism of ethanol reward, and the role of nAChRs, from a genetic angle in order to 
elucidate more subunit-specific involvement. Chapters II-IV use mouse models in which 
a gene encoding a specific nAChR subunit has been knocked out. In Chapter II and IV 
the CHRNA4 gene, encoding the α4 nAChR subunit, is knocked out as described 
previously (Ross, Wong et al. 2000), with Chapter II focusing solely on the effect on 
males. In Chapters III and IV, CHRNA6, encoding the α6 nAChR subunit, is knocked 
out, as described by Champtiaux et al. (2002).  
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CHAPTER II: Nicotinic Acetylcholine Receptors Containing the α4 
Subunit Modulate Alcohol Reward 
Abstract 
Background:  Nicotine and alcohol are the two most co-abused drugs in the world 
suggesting a common mechanism of action may underlie their rewarding properties. 
While nicotine elicits reward by activating ventral tegmental area (VTA) dopaminergic 
(DAergic) neurons via high affinity neuronal nicotinic acetylcholine receptors (nAChRs), 
the mechanism by which alcohol activates these neurons is unclear.   
Methods:  Because the majority of high affinity nAChRs expressed in VTA DAergic 
neurons contain the α4 subunit, we measured ethanol-induced activation of DAergic 
neurons in midbrain slices from two complementary mouse models, an α4 knock-out 
(KO) mouse line and a knock-in line (Leu9'Ala) expressing α4 subunit-containing 
nAChRs hypersensitive to agonist compared to wild-type (WT).  Activation of DAergic 
neurons by ethanol was analyzed using both biophysical and immunohistochemical 
approaches in midbrain slices.  The ability of alcohol to condition a place preference in 
each mouse model was also measured. 
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Results:  At intoxicating concentrations, ethanol activation of DAergic neurons was 
significantly reduced in α4 KO mice compared to WT.  Conversely, in Leu9'Ala mice, 
DAergic neurons were activated by low ethanol concentrations that did not increase 
activity of WT neurons.  In addition, alcohol potentiated the response to ACh in DAergic 
neurons, an effect reduced in α4 KO mice.  Paralleling alcohol effects on DAergic neuron 
activity, rewarding alcohol doses failed to condition a place preference in α4 KO mice, 
whereas a sub-rewarding alcohol dose was sufficient to condition a place preference in 
Leu9'Ala mice.  
Conclusions:  Together, these data indicate that nAChRs containing the α4 subunit 
modulate alcohol reward.   
Introduction 
 As many as 88-96 % of alcoholics are also smokers and the majority of smokers 
(~60 %) binge drink or consume significant amounts of alcohol (Batel, Pessione et al. 
1995, Hurt, Offord et al. 1996).  These statistics suggest that the abusive properties of 
tobacco and alcohol may, at least partly, share a common mechanism of action. 
Alternatively, the effects of one drug may modulate the rewarding properties of the other. 
Indeed, within the mesocorticolimbic reward circuitry of the brain, both drugs stimulate 
dopaminergic (DAergic) neurons in the ventral tegmental area (VTA), ultimately 
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increasing dopamine (DA) release in the nucleus accumbens (NAcc), a phenomenon 
widely associated with drug reinforcement (Pidoplichko, DeBiasi et al. 1997, Rodd, 
Melendez et al. 2004, Okamoto, Harnett et al. 2006, Tsai, Zhang et al. 2009).  However, 
while nicotine initiates activation of DAergic neurons by binding to and activating 
neuronal nicotinic acetylcholine receptors (nAChRs) (Pidoplichko, DeBiasi et al. 1997, 
Maskos, Molles et al. 2005), the mechanism by which alcohol activates DAergic neurons 
is unclear (McBride, Lovinger et al. 2004, Okamoto, Harnett et al. 2006, Dopico and 
Lovinger 2009). 
 Neuronal nAChRs are ligand-gated cation channels that, under normal conditions, 
are activated by the endogenous neurotransmitter, ACh (Tapper 2006, Albuquerque, 
Pereira et al. 2009).  Twelve vertebrate genes encoding neuronal nAChR subunits have 
been identified (α2-α10, β2-β4) with five subunits coassembling to form a functional 
receptor (Laviolette and van der Kooy 2004, Albuquerque, Pereira et al. 2009).  The 
majority of nAChRs with high affinity for agonist are heteromeric consisting of two or 
three α subunits co-assembled with two or three β subunits while a subset of low affinity 
receptors are homomeric, mostly consisting of α7 subunits (Albuquerque, Pereira et al. 
2009).   
 While alcohol is not a direct agonist of nAChRs, it has been hypothesized that 
ethanol induces an increase in ACh release from lateral dorsal tegmentum (LDTg) 
cholinergic neuron input into the VTA which could potentially drive activation of 
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DAergic neurons through nAChRs (Larsson, Edstrom et al. 2005).  Ethanol also 
potentiates the response to ACh for high affinity, but not low affinity nAChRs (Cardoso, 
Brozowski et al. 1999, Zuo, Kuryatov et al. 2002), but whether potentiation occurs in 
DAergic neurons is unknown.  Systemic injection or VTA infusion of the non-selective 
nAChR antagonist mecamylamine reduces ethanol induced NAcc DA release, alcohol 
consumption and reinforcement in rodents (Blomqvist, Engel et al. 1993, Blomqvist, 
Ericson et al. 1997, Ericson, Blomqvist et al. 1998, Hendrickson, Zhao-Shea et al. 2009). 
Furthermore, mecamylamine has been shown to reduce the voluntary subjective euphoric 
effects of alcohol (Chi and de Wit 2003).  More recently, the FDA approved smoking 
cessation drug, varenicline, can reduce alcohol consumption and seeking in rodents, 
partly via an α4* nAChR-dependent mechanism (* denotes that other subunits in addition 
to α4 are components of the functional receptors), and reduces consumption in heavy 
smoking alcoholics (Steensland, Simms et al. 2007, McKee, Harrison et al. 2009, 
Hendrickson, Zhao-Shea et al. 2010, Kamens, Andersen et al. 2010, Hendrickson, 
Gardner et al. 2011).  While these data implicate a role for nAChRs in alcohol 
consumption and reinforcement, a direct involvement of nAChR function in alcohol-
induced activation of VTA DAergic neurons has not been demonstrated. 
 We sought to test the hypothesis that nAChRs contribute to alcohol-induced 
activation of VTA DAergic neurons and that alcohol reward could be modulated via α4* 
nAChR activation.   
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Materials and Methods 
Animals  
C57BL/6J male mice (Jackson Laboratory, West Grove, PA, USA) were used in all 
experiments, in addition to α4 knockout (KO) homozygous mice, Leu9'Ala heterozygous 
and their respective wild-type (WT) littermates as indicated. All experiments were 
conducted in accordance with the guidelines for care and use of laboratory animals 
provided by the National Research Council (National Research Council 1996), as well as 
with an approved animal protocol from the Institutional Animal Care and Use Committee 
of the University of Massachusetts Medical School. 
Slice preparation 
Mice (4-6 weeks old) were anesthetized by intraperitoneal (i.p.) injection of sodium 
pentobarbital (200 mg/kg) and then decapitated. Brain slices were cut as previously 
described (Liu, Zhao-Shea et al. 2012). 
Electrophysiological recordings 
Individual slices were transferred to a recording chamber continually superfused with 
oxygenated ACSF (30–32 °C) at a flow rate of ~ 2 ml/min. Cells were visualized using 
infrared differential interference contrast (IR–DIC) imaging on an Olympus BX-50WI 
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microscope. Electrophysiological recordings were recorded using a Multiclamp 700B 
patch-clamp amplifier (Axon Instruments, Foster City, CA).  For a detailed description of 
recording methodology, see supplemental materials and methods. Immunohistochemistry 
Adult (8-10 weeks) male α4 KO mice and their WT littermates, as well as heterozygous 
Leu9′Ala mice and their WT littermates were i.p. injected with saline for three days prior 
to the start of the experiment to habituate them to handling and to reduce c-Fos activation 
due to stress.  Mice were injected with ethanol and their brains were harvested and 
processed for immunohistochemistry 90 min post injection (see supplemental material 
and methods for details).   
Conditioned Place Preference  
The ethanol conditioned place preference (CPP) assay consisted of a three chamber 
apparatus (Med Associates). The two conditioning chambers were contextually distinct: 
One had white walls while the other had black walls and one chamber had mesh metal 
floors while the other had rod metal floors.   The conditioning chambers were separated 
by a neutral grey chamber.  Experiments were conducted over 6 consecutive days as in 
Gibb et al. (2011).   
Ethanol metabolism 
Prior to an ethanol injection, blood was obtained from the tail vein (~30 µL each time 
point) to provide a zero point for each animal.  After a 2 g/kg i.p. injection of ethanol, 
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blood samples were taken at intervals of 30, 60, 90, and 120 min.  Blood was collected in 
heparinized capillary tubes, centrifuged at 1500Xg for 5 minutes and blood analyzed 
using an alcohol oxidase-based assay.  Blood ethanol concentrations were measured on a 
GM7 Micro-Stat Analyzer (Analox Instruments Ltd.)  
Data analysis 
AP spikes were detected using a threshold detection protocol contained within pClampfit 
(pClamp v10.2, Axon Inst., Molecular Devices). Average fold changes in AP frequency 
are presented as means ± standard errors of means (SEM).  A Paired T-test was used to 
analyze differences between AP frequency at baseline (1 minute prior to drug application) 
and after a 5-min application of ethanol. Behavioral and immunohistochemistry data were 
analyzed using One-way or Two-way ANOVAs with genotype and treatment as variables 
followed by Bonferroni post hoc tests as indicated. Results were considered significant at 
p < 0.05. All data are expressed as means ± standard errors of means (SEM). 
Results  
 Cell-attached patch clamp recordings were made from VTA DAergic neurons in 
C57BL/6J mouse slices.  Slices were cut in the sagittal plane allowing for preservation of 
cholinergic input from LDTg into the VTA.    To test the effects of ethanol on DAergic 
neuron activity, AP frequency was monitored in cell-attached mode at baseline, during 
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application of an intoxicating concentration of alcohol (100 mM), and after wash-out. 
Because the focus of our experiments was to uncover the contribution of nAChR 
activation in response to alcohol, recordings were made in the presence of a cocktail of 
inhibitors to block muscarinic receptor, AMPA receptor, and GABAA receptor activities 
(see methods).  Five-minute bath application of 100 mM ethanol produced a significant 
increase in AP frequency (~33 % increase from baseline, Fig 2.1A, D) that was 
completely reversed upon wash out.  To determine if the inhibitor cocktail affected the 
firing rates of DAergic neurons in response to alcohol, we measured alcohol responses in 
the absence of antagonists.  Bath application of 100 mM ethanol produced a significant 
increase in AP frequency that was slightly larger than responses in the presence of the 
inhibitor cocktail but this increase was not statistically significant (Fig. 2.1D, bottom 
panel).  Thus, the inhibitor cocktail was included in the remainder of slice physiology 
experiments. To test the hypothesis that activation of nAChRs is necessary for the 
observed ethanol-mediated increase in VTA DAergic neuron activity, we bath-applied 10 
µM mecamylamine prior to and during application of ethanol.  Mecamylamine alone did 
not affect baseline firing of VTA DAergic neurons (Fig. 2.1B, D top panel).  However, in 
the presence of mecamylamine, alcohol failed to significantly increase DAergic neuron 
activity above baseline (Fig. 2.1B, D) indicating that nAChR activation is necessary for 
alcohol-induced activation of DAergic neurons.    
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 To test the hypothesis that activation of low affinity α7 nAChRs were critical for 
the observed alcohol-induced increase in DAergic neuron activity, we bath-applied the α7 
selective antagonist MLA (10 nM) prior to and during application of ethanol.   MLA had 
little effect on baseline firing of DAergic neurons (Fig. 2.1C, D top panel).  However, in 
contrast to mecamylamine, ethanol significantly increased DAergic neuron activity 
compared to baseline (~33 %) in the presence of MLA suggesting that nAChRs 
containing the α7 subunit do not contribute to ethanol-mediated activation of VTA 
DAergic neurons (Fig. 2.1C, D).    
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Figure 2.1 Ethanol activation of VTA DAergic neurons. A)  Representative action 
potential firing frequency histogram from a VTA DAergic neuron before, during, and 
after 5-min bath application of 100 mM ethanol (EtOH) alone (n = 10) or in the presence 
of B) 10 µM mecamylamine (MEC, n = 7) or C) 100 nM MLA (n = 5). Action potentials 
were recorded in cell-attached mode.  Representative action potential traces (top of each 
panel, a, b, c) are shown from the corresponding times on the histograms. D. Average 
time course of ethanol responses in each condition is shown (top panel).  Each data point 
represents the average 1-min firing frequency normalized to baseline for each recording. 
The bar over the averaged frequency plot represents the duration of ethanol application. 
Recording times between groups were aligned based on time of ethanol application to 
facilitate comparison. Antagonists were applied at times indicated in the individual 
histograms as indicated in B and C. (Bottom panel) Fold-change in average firing 
frequency at baseline (1 min. prior to alcohol application, dotted line) compared to 5 min 
of ethanol application for each condition. ### p < 0.001, #### p < 0.0001, baseline 
frequency (1 min prior to drug application) compared to 5 min alcohol exposure, paired t-
tests.   ** p < 0.01, Students t-test (effect of ethanol or ethanol + MLA on AP frequency 
compared to ethanol + MEC). n = 6-10 neurons/condition. (Performed, analyzed by 
Liwang Liu) 
Expression of α4* nAChRs modulates alcohol-induced activation of VTA DAergic 
neurons.  As previous studies indicate that the majority of high affinity nAChRs in VTA 
DAergic neurons express the α4 subunit and that nAChRs containing the α4 subunit are 
both necessary and sufficient for nicotine reward (Tapper, McKinney et al. 2004, Pons, 
Fattore et al. 2008, Zhao-Shea, Liu et al. 2011), we sought to investigate the contribution 
of α4* nAChRs to alcohol-induced activation of VTA DAergic neurons in two 
complementary mouse models, the α4 KO mouse which does not express α4* nAChRs 
(Ross, Wong et al. 2000) and a knock-in mouse line that expresses a single point mutation 
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(Leu9'Ala) in the α4 subunit that renders receptors containing the subunit hypersensitive 
to agonist (Tapper, McKinney et al. 2004, Fonck, Cohen et al. 2005).  
 No significant difference in baseline firing frequency of DAergic neurons was 
observed between WT and α4 KO animals (5.0 ± 1.8 and 4.0 ± 1.0 Hz, respectively) as 
reported previously (Zhao-Shea, Liu et al. 2011, Liu, Zhao-Shea et al. 2012).  In WT 
mice, bath application of 50 or 100 mM alcohol significantly increased DAergic neuron 
activity (~23 % and ~33 % above baseline, Fig. 2D, top panel).  In contrast, 50 mM 
ethanol did not significantly increase VTA DAergic neuron activity of α4 KO mice 
compared to baseline; whereas 100 mM ethanol elicited a modest increase (~10 % above 
baseline, Fig. 2A, C, D top panel) compared to baseline. This increase was significantly 
lower than the effect of 100 mM alcohol on WT DAergic neurons (Fig. 2.2D top panel).   
 There was no significant difference in baseline DAergic neuron firing rates 
between Leu9'Ala mice and their WT littermates.  However, in contrast to α4 KO mice, 
Leu9'Ala DAergic neurons were robustly activated by 100 mM alcohol (Fig. 2.2B, C, D 
bottom panel).  Whereas WT DAergic neurons responded to 100 mM alcohol by an 
increased firing rate of ~30 % compared to baseline, Leu9'Ala DAergic neurons increased 
~60 %, and was significantly different from WT (Fig. 2.2B, D bottom panel).   To test the 
hypothesis that low sub-activating alcohol concentrations are sufficient to increase VTA 
DAergic neuron firing rates in Leu9'Ala mice, DAergic activity was also recorded in 
response to 20 mM alcohol.  At this concentration, alcohol did not significantly increase 
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VTA DAergic neurons firing rates compared to baseline in WT slices (Fig. 2.2D bottom 
panel).  By contrast, 20 mM alcohol elicited a modest (~15 %), but significant  increase 
in DAergic neuron activity in Leu9'Ala slices.   Together, these data indicate that 
activation of α4* nAChRs can contribute to alcohol-induced activation of VTA DAergic 
neurons. 
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Figure 2.2 Functional α4* nAChR expression modulates DAergic neuron activation 
by ethanol.  Representative action potential firing frequency histogram from a VTA 
DAergic neuron before, during, and after a 5-min bath application of 100 mM ethanol in 
sagittal midbrain slices from A) α4 KO and B) Leu9'Ala mice. Representative action 
potential traces (top of each panel, a, b, c) are shown from the corresponding times on the 
histograms.  C) Time course of the effects of ethanol on average normalized frequency 
for each genotype are shown (n = 8-10 neurons/genotype). Ethanol (100 mM) was 
applied at the times indicated by the bar.  D.  Fold-change in average firing frequency in 
response to 100 mM ethanol in WT (n = 8) and α4 KO mice (n = 15), 20 mM in WT (n = 
5) and Leu9'Ala mice (n = 8), and 100 mM ethanol in WT (n = 10) and Leu9'Ala mice (n 
= 13).  #p < 0.05, ##p < 0.01, ###p < 0.001, ####p < 0.0001, as in 2D.  * p < 0.05, ** p < 
0.01 response to alcohol compared between genotypes,  One-way ANOVA, Bonferroni 
post-test. (Performed, analyzed by Liwang Liu) 
Alcohol potentiates the response to ACh in DAergic neurons by an α4* nAChR-dependent 
mechanism.  To test the hypothesis that ethanol may potentiate the response to ACh in 
VTA DAergic neurons, we bath-applied ACh (300 µM) in the absence and presence of 
alcohol and measured effects on firing frequency.  In WT mice, ACh alone elicited an 
increase in VTA DAergic neuron firing frequency that was significantly greater than 
baseline (~25 %, Fig 2.3A, E, F).  Co-application of either 50 or 100 mM ethanol with 
ACh elicited a robust increase in firing frequency (~2 fold) which was significantly 
greater than the response of ACh alone and  persisted for several minutes after application 
before returning to baseline (Fig. 2.3B, E, F).  Pre-incubation of the slice with DHβE 
significantly reduced the response to ACh plus 50 mM ethanol (Fig. 2.3C, E, F).  Finally, 
the effect of ACh plus 50 mM ethanol on DAergic neuron firing frequency was 
significantly reduced in slices from α4 KO mice compared to WT slices (Fig. 2.3D, E, 
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F).  Together, these data indicate that alcohol potentiates the response to ACh at α4* 
nAChRs.    
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Figure 2.3 Alcohol potentiates the response of DAergic neurons to ACh. A) 
Representative action potential firing frequency histogram from a VTA DAergic neuron 
before, during, and after 10-min bath application of 300 µM ACh.  Representative action 
potential traces (top of each panel, a, b, c) are shown from the corresponding times on the 
histograms.  Representative action potential firing frequency histogram from a VTA 
DAergic neuron before, during, and after 10-min bath co-application of 300 µM ACh and 
50 mM ethanol in the absence (B), or presence (C) of 1 µM DHβE.   D) Representative 
action potential firing frequency histogram from an α4 KO VTA DAergic neuron before, 
during, and after 10 min bath co-application of 300 µM ACh and 50 mM ethanol.       E) 
Time course of the effects of ethanol on average normalized frequency under each 
condition are shown (n = 6-12 neurons/genotype). ACh ± ethanol was applied at the times 
indicated by the bar.  Recording times between groups were aligned based on time of 
ethanol application to facilitate comparison. F)  Fold-change in average DAergic neuron 
firing frequency in response to 300 µM ACh alone (n = 6), in the presence of 50 (n = 12) 
or 100 mM (n = 5) ethanol, in the presence of 50 mM ethanol and DHβE (n = 6), or in the 
presence of 50 mM ethanol in α4 KO slices (n = 10).    #p < 0.05 as in 1D.  * p < 0.05 
response to alcohol compared between treatments/genotypes. 
Alcohol induction of c-Fos expression in VTA DAergic neurons requires functional 
expression of α4* nAChRs.  Previously, using c-Fos as a marker for neuronal activation 
and TH as a marker for DAergic neurons, we demonstrated that ethanol activates 
DAergic neurons of the VTA and that this activation can be blocked by a pre-injection of 
the nAChR antagonist mecamylamine (Hendrickson, Zhao-Shea et al. 2009).  To 
determine if α4* nAChRs are necessary for this activation, we challenged WT and α4 KO 
mice with saline or 2.0 g/kg ethanol and examined their brains for c-Fos expression 
within TH(+) neurons 90 min. post-injection (Fig. 2.4).  Because previous studies 
indicate alcohol induces c-Fos in DAergic neurons preferentially in the posterior VTA 
(Rodd, Bell et al. 2004, Hendrickson, Zhao-Shea et al. 2010), we focused on this region 
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for analysis.  Overall there was a significant main effect of genotype (F(1,8) = 8.15, 
p<0.05), treatment (F(1,8) = 12.28, p<0.01) and a significant genotype × treatment 
interaction (F(1,8) = 13.25, p<0.01).  Bonferroni post-test indicated a significant difference 
between number of TH(+), c-Fos(+) neurons in WT and α4 KO mice after 2.0 g/kg 
ethanol, but not saline (Fig. 2.4A, B, C).  In addition, the % of TH(+) neurons that were 
also c-Fos(+) significantly differed between WT and α4 KO mice after 2.0 g/kg ethanol, 
but not saline (Table 2.1). WT mice injected with 2.0 g/kg ethanol had significantly 
higher expression of c-Fos compared to α4 KO mice injected with 2.0 g/kg ethanol (Fig 
2.4C).  One-way ANOVA also indicated that WT mice treated with 2.0 g/kg ethanol had 
significantly increased c-Fos expression compared to a saline injection (Fig 2.4C), 
whereas the same dose of ethanol had no effect in α4 KO mice compared to a saline 
injection. 
 To determine if increasing α4* nAChR agonist sensitivity resulted in activation of 
VTA DAergic neurons with lower doses of alcohol, we challenged WT and Leu9'Ala 
mice with two concentrations of ethanol, 2.0 g/kg and a low dose of 0.5 g/kg, and 
analyzed their brains for c-Fos expression in TH(+) neurons as above.  Two-Way ANOVA 
revealed a significant main effect of treatment (F(2,14) = 22.01, p < 0.001), genotype (F(1,14) 
= 11.65, p < 0.01) and a significant treatment × genotype interaction (F(2,14) = 8.97, p < 
0.01).  A Bonferroni post-test indicated that Leu9'Ala mice treated with 0.5 g/kg had 
significantly increased number of TH(+), c-Fos(+) neurons compared to WT mice (Fig 
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2.4D, E, F).  The % of total TH(+) neurons that were also c-Fos(+) was increased in 
Leu9’Ala mice compared to WT after a 0.5 g/kg ethanol challenge (Data not shown). 
Additionally, one-way ANOVAs revealed that Leu9'Ala mice treated with 0.5 g/kg and 
2.0 g/kg ethanol had significantly increased numbers of TH(+), c-Fos(+) neurons 
compared to a saline challenge while WT mice treated with 2.0 g/kg had significantly 
increased numbers of TH(+), c-Fos(+) neurons compared to both saline and 0.5 g/kg 
alcohol.  Together, these data indicate that expression of α4* nAChRs are necessary for 
alcohol-induced activation of VTA DAergic neurons and that α4* nAChR activation 
controls DAergic neuron response to alcohol. 
 
WT: 0.5 g/kg EtOHDWT: 2 g/kg EtOHA
Leu9'Ala: 0.5 g/kg EtOHEα4 KO: 2 g/kg EtOHB
C F
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Figure 2.4  Ethanol-induced c-Fos expression in VTA TH(+) neurons is dependent on 
expression and activation of α4* nAChRs.  Representative photomicrographs 
illustrating midbrain sections of the posterior VTA from A) WT mice and B) α4 KO mice 
injected with 2 g/kg ethanol.  Sections were immunolabeled for TH (red) and c-Fos 
(green).  White boxes delineate slice regions that are magnified in the adjacent 
photomicrographs. White arrowheads point to neurons that are TH (+), c-Fos (+).  Scale 
bar = 100 µm.  Merged images are shown. C) Number of TH (+) c-Fos (+) neurons per 
slice taken from mice given an i.p. injection of 2 g/kg ethanol.  Forty-eight slices/
treatment/mouse were analyzed, n = 3 mice/treatment. D.  Representative 
photomicrographs illustrating midbrain sections of the posterior VTA from WT mice and 
E) Leu9'Ala mice injected with 0.5 g/kg ethanol.  Sections were immunolabeled for TH 
and c-Fos as in panels A and B.  F) Average number of TH (+), c-Fos (+) neurons/slice 
calculated from mice given an i.p. injection of 0.5 g/kg or 2 g/kg ethanol.  Forty-eight 
slices/treatment/mouse were analyzed, n = 3 mice/treatment. One-way ANOVA and 
Bonferroni post-test comparing saline to ethanol treatments in WT, α4 KO, or Leu9'Ala 
mice was used, ##p<0.01, ###p<0.001 .  Two-way ANOVA and Bonferroni post-test 
comparing treatments in WT and α4 KO mice was also used, ** p < 0.01, ***p<0.001. 
(Performed and analyzed by Rubing Zhao-Shea and Linzy M. Hendrickson)  
  
Functional expression of α4* nAChRs modulates alcohol reward.  As activation of VTA  
DAergic neurons is sufficient for reward (Tsai, Zhang et al. 2009), and both our 
physiology and immunohistochemical data indicate a role for α4* nAChRs in alcohol-
induced activation of VTA DAergic neurons, we evaluated alcohol rewarding properties 
in α4 KO and Leu9'Ala mouse lines using the CPP assay, a robust behavioral assay of 
rewarding stimuli (Cunningham, Gremel et al. 2006).  In C57BL/6J mice, the background 
strain for both α4 mouse models, 2.0 g/kg has been established as a rewarding dose of 
alcohol (Tzschentke 2007).  Consistent with this observation, WT mice that received i.p. 
injections of 2.0 g/kg ethanol in the drug-paired chamber significantly preferred the 
alcohol-paired chamber over the saline-paired chamber after training compared to 
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baseline (expressed as the difference score, post-training minus pre-training for each 
chamber, F(1, 48) = 58.2, p < 0.001, Fig. 2.5A).  In addition, the total time spent in the 
alcohol-paired chamber after training was greater that the time spent in the same chamber 
before training (Table S2, F(1, 48) = 22.0, p < 0.001).   In α4 KO mice, there was a modest 
but statistically significant difference in the difference score between ethanol-paired and 
saline-paired chambers (p < 0.05, F (1, 20) = 5.6, Fig. 2.5A).  However, the ethanol 
difference score in α4 KO mice was significantly lower than the equivalent ethanol 
difference score in WT mice (F(1, 34) = 9.49, p < 0.01).  In addition, α4 KO mice did not 
spend significantly greater time in the alcohol-paired chamber during the test day 
compared to the pre-training, habituation day (Table 2.1, NS) indicating that this alcohol 
dose was weakly rewarding in these animals.    
 To test the hypothesis that Leu9'Ala mice are more sensitive to alcohol reward, we 
tested a sub-rewarding dose of alcohol, 0.5 g/kg, in these animals.  In WT mice, 0.5 g/kg 
ethanol failed to condition a place preference (Fig. 2.5A, NS).  However, Leu9'Ala mice 
significantly preferred the alcohol-paired chamber compared to the saline-paired chamber 
(Fig. 2.5A, F(1,22) = 8.57, p < 0.01).  Leu9'Ala mice also spent significantly more total 
time in the alcohol-paired chamber during the post-training test day compared to the pre-
training habituation day, indicating a low dose of alcohol was rewarding in these animals 
(Table 2.1, F(1,22) = 8.33, p < 0.01).  In response to 2.0 g/kg alcohol, Leu9’Ala mice 
displayed a more modest preference for the ethanol-paired compared to the saline-paired 
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chamber (F(1, 22), p < 0.05).  However, total time spent in the ethanol paired chamber after 
training did not reach significance compared to time spent in the alcohol-paired chamber 
during habituation.  Thus, alcohol displayed an inverted “U” shaped dose response 
relationship in Leu9'Ala mice.  As a negative control in Leu9'Ala mice we also measured 
time spent in the drug paired chamber in response to saline injections in both chambers 
during training.  There was no significant preference for either chamber after training 
with saline injections nor was there a difference in time spent during the saline-paired 
chamber during the test day compared to the habituation day, indicating a specific effect 
of the low alcohol dose in these animals (Fig. 2,5A, Table 2.1).  
  Because genotype differences in locomotor activity could influence CPP results, 
we measured baseline locomotion in WT, α4 KO, and Leu9’Ala mice.  No significant 
differences in activity were detected over the course of 30 min (Fig. 2.5B).  Finally, 
differences in rewarding properties of alcohol between WT, α4 KO and Leu9'Ala mice 
could be a consequence of altered pharmacokinetics of ethanol between genotypes. To 
address this possibility, we measured blood ethanol concentrations (BEC) in WT, α4 KO, 
and Leu9'Ala mice every 30 min after an acute i.p. injection of 2.0 g/kg to monitor 
alcohol clearance (Fig. 2.5C).  Two-Way ANOVA revealed an overall significant effect of 
time (F(4,44) = 139.0, p < 0.0001) but not genotype on BEC.  In addition, there was no 
significant time × genotype interaction.  Together, these data indicate that activation of 
α4* nAChRs modulates alcohol reward.        
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Figure 2.5  α4* nAChR expression modulates alcohol reward.  A.  Average difference 
score (test – baseline) in ethanol-paired (black bars) and saline-paired (white bars) 
chambers in Leu9'Ala, WT, and α4 KO mice in response to the alcohol doses indicated. 
Because each line has been back-crossed at least ten generations to the C57Bl/6J strain 
and no differences in alcohol responses between α4 KO and Leu9'Ala WT littermates 
were detected, WT mice were combined.    n = 9 – 22 mice/dose. multiple t-tests * p < 
0.05, ** p < 0.01, *** p < 0.001 compared to saline.    B.  Locomotor activity 
(ambulation) in WT, Leu9'Ala, and α4 KO mice.  Each data point represents the average 
total locomotor activity over 5-min (n=5-10 mice/genotype). C.  Blood ethanol 
concentration at 30-min intervals after an acute, 2.0 g/kg i.p. injection of alcohol in WT, 
α4 KO, and Leu9'ala mice (n = 3-4 mice/genotype).   
Table 2.1 Total time spent (seconds) in saline-paired, ethanol-paired, and neutral (gray) 
chamber during habituation (Hab) and after training (Test) in WT, α4 KO, and Leu9’Ala 
mice.  
A B C
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Discussion 
 Alcohol and nicotine are often co-abused suggesting that they may share a 
common mechanism of action in the CNS.  Here we show that, in VTA midbrain slices, 
alcohol significantly increased DAergic neuron activity, an effect that was blocked by 
mecamylamine indicating a critical role for nAChRs in alcohol-induced activation of 
these neurons.  This observation is also in agreement with our previous data illustrating 
that mecamylamine prevents alcohol-induced c-Fos expression in VTA DAergic neurons 
after an alcohol challenge (Hendrickson, Zhao-Shea et al. 2009).    
  Previously, we demonstrated that VTA DAergic neurons that are activated by 
alcohol, robustly express α4, α6, and β3 nAChR subunits (Hendrickson, Zhao-Shea et al. 
2010).  In addition, the smoking cessation aid, varenicline, targets VTA α4β2* nAChRs to 
reduce alcohol consumption (Hendrickson, Zhao-Shea et al. 2010, Hendrickson, Gardner 
et al. 2011) although other nAChR subtypes in additional brain regions may also 
contribute (Kamens, Andersen et al. 2010, Chatterjee, Steensland et al. 2011).  Using two 
complementary genetic mouse models, our data indicate that α4* nAChRs are important 
for ethanol-induced activation of VTA DAergic neurons.  A leftward shift of the agonist 
sensitivity of these receptors (Lester, Fonck et al. 2003) lowered the concentration of 
alcohol required to activate these neurons, indicating that α4* nAChR agonist sensitivity 
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can directly modulate VTA DAergic neuron activation by alcohol.  Finally, ethanol 
potentiated DAergic neuron activation by ACh, a phenomenon that was blocked by 
DHβE and reduced in α4 KO slices.  It is important to note that alcohol responses in α4 
KO DAergic neurons were not completely abolished indicating other nAChR subtypes or 
non-nAChR mechanisms may be involved.  However, these data indicate that if alcohol 
increases ACh concentration in the VTA, then not only will elevated ACh concentrations 
activate DAergic neuron nAChRs, but alcohol will potentiate this response.  One 
limitation of our physiology data stems from the fact that mesocortical slices may not 
include critical circuitry influencing VTA activity.  In addition, we did not differentiate 
sub-populations of DAergic neurons that may exist and express distinct nAChR subtypes 
within the VTA (although the vast majority express α4* nACRs) (Yang, Hu et al. 2009, 
Zhao-Shea, Liu et al. 2011).  Interestingly, expression and function of α4* nAChRs not 
only contributed to activation of DAergic neurons in slices, but also modulated ethanol 
induction of c-Fos expression in VTA DAergic neurons.  Taken together, these data 
strongly suggest that expression of functional α4* nAChRs can modulate activation of 
the mesolimbic reward pathway by alcohol. 
  Previous studies indicate that the rewarding properties of ethanol, as measured by 
CPP, is expressed through a VTA-dependent mechanism (Bechtholt and Cunningham 
2005).   Thus, because alcohol activation of DAergic neurons is reduced in α4 KO mice, 
alcohol CPP is weak in these animals, although it is possible that alcohol may condition a 
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place preference in response to higher doses of alcohol.  Conversely, a sub-rewarding 
dose of alcohol is sufficient to condition a place preference in Leu9'Ala mice, presumably 
because VTA DAergic neurons in these animals are more robustly activated by such low 
doses of alcohol. Previous data indicate that α4 KO mice acutely consume less alcohol 
than WT mice in the drinking-in-the-dark paradigm consistent with a role for α4* 
nAChRs in reward (Hendrickson, Zhao-Shea et al. 2010, Hendrickson, Gardner et al. 
2011).  However, when given a 2 % or 20 % alcohol bottle in the DID assay, Leu9'Ala 
mice alcohol consumption did not significantly differ compared to WT mice.  This may 
be due to the fact that consumption was analyzed immediately after saline or drug 
injections which could influence consumption behavior.  Thus, baseline consumption 
behavior should be measured in Leu9’Ala mice using a variety of alcohol concentrations 
in the absence of injections.  Because blocking alcohol reward might reduce alcohol 
consumption, our data raise the possibility that α4* nAChRs in the VTA may be useful 
molecular targets for alcohol cessation therapies. Indeed, in addition to varenicline, 
recently sazetidine-A, an α4β2-selective nAChR desensitizing agent, has been shown to 
reduce alcohol consumption in rodents (Rezvani, Slade et al. 2010).    
 Prior studies using nAChR subtype-selective antagonists have attempted to 
identify the subunit composition of nAChRs that may influence alcohol-induced DA 
release in NAcc and alcohol self-administration in rodents.  Our lab and others have 
found that systemic injection of MLA does not reduce alcohol consumption in rodents 
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(Larsson, Svensson et al. 2002, Larsson, Jerlhag et al. 2004, Hendrickson, Zhao-Shea et 
al. 2009) indicating that low affinity α7 nAChRs do not play a significant role in alcohol 
reward.  This is also in agreement with our physiology data indicating a lack of effect of 
MLA on ethanol-induced activation of DAergic neurons.  In addition, systemic injection 
of the α4β2* nAChR competitive antagonist DHβE also fails to reduce ethanol intake in 
both rats and mice (Larsson, Svensson et al. 2002, Ericson, Molander et al. 2003) at 
lower doses but has been shown to reduce self-administration in rats at higher doses 
(Kuzmin, Jerlhag et al. 2009).  Thus, it is likely that the ability of DHβE to block α4β2* 
nAChRs depends on the stoichiometry of the target receptor population (Moroni, Zwart 
et al. 2006) and subunit composition.  For example, we recently identified functional 
nAChRs in VTA DAergic neurons that are of the α4α6(β2)(β3) subtype (Liu, Zhao-Shea 
et al. 2012) which we would expect to be more resistant to blockade by DHβE compared 
to nAChRs consisting of purely α4 and β2 subunits (Grady, Salminen et al. 2007). 
Although a recent study found that α6 and β3 KO mice did not consume or prefer alcohol 
differently than WT mice, caution in interpretation is warranted as these KO animals may 
exhibit compensatory changes in nAChR expression during development that may 
influence alcohol reinforcement (Kamens, Hoft et al. 2012).  Thus, further experiments 
will need to be done to identify additional nAChR subunits involved in alcohol-mediated 
activation of VTA DAergic neurons and alcohol reward.   
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 To our knowledge, this is the first study directly implicating α4* nAChRs -
molecules that are known to play a primary role in nicotine reward- in the rewarding 
properties of alcohol.  Our data indicate that activation of α4* nAChRs in the VTA 
modulates alcohol reward, suggesting their potential usefulness as therapeutic targets.    
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CHAPTER III: Modulation of Ethanol Reward by Nicotinic 
Acetylcholine Receptors Containing the α6 Subunit 
Abstract 
 The prevalent co-abuse of nicotine and alcohol suggests a common neural 
mechanism underlying the actions of the two drugs. Nicotine, the addictive component of 
tobacco, activates nicotinic acetylcholine receptors (nAChRs) containing the α6 subunit 
(α6* nAChRs) in dopaminergic (DAergic) neurons of the ventral tegmental area (VTA), a 
region known to be crucial for drug reward. Recent evidence suggests that ethanol may 
potentiate ACh activation of these receptors as well, although whether α6* nAChR 
expression is necessary for behavioral effects of acute ethanol exposure is unknown. We 
compared binge-like ethanol consumption and ethanol reward sensitivity between knock-
out mice that do not express chrna6 (the gene encoding the α6 nAChR subunit, the α6 
KO line) and wild-type (WT) littermates using the Drinking-in-the-Dark (DID) and 
Conditioned Place Preference (CPP) assay, respectively.  In the DID assay, α6 KO female 
and male mice consumed ethanol similarly to WT mice at all concentrations tested. In the 
CPP assay, 2.0 g/kg and 3.0 g/kg, but not 0.5 mg/kg ethanol conditioned a place 
preference in WT female and male mice; whereas only 2.0 g/kg ethanol conditioned a 
place preference in α6 KO mice.  Acute challenge with ethanol reduced locomotor 
activity similarly between genotypes in both female and male mice.  Together, these data 
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indicate that expression of α6* nAChRs is not absolutely required for binge-like ethanol 
consumption and reward, but modulate sensitivity to the rewarding properties of the drug.  
Introduction  
 Alcohol use disorders (AUDs) and the abuse of alcohol lead to 3.3 million deaths 
annually worldwide, and are responsible for 25% of deaths in people age 20-39 (WHO 
2015), making it one of the leading causes of preventable mortality in the world 
(Mokdad, Marks et al. 2004). Despite the costs of alcohol use and abuse, both in human 
life and in the economic burden placed on society (CASA 2000), there remain few viable 
treatment options for those suffering from AUDs (Spanagel 2009) highlighting the need 
for a better understanding of the mechanism(s) underlying the effects of alcohol on 
relevant neural circuitry within the brain. The frequent co-abuse of alcohol and nicotine, 
with an estimated 70-75% of alcoholics also identifying as tobacco-dependent (Miller 
and Gold 1998), suggest a common mechanism of the two drugs. Nicotine and alcohol 
activate dopaminergic (DAergic) neurons of the ventral tegmental area (VTA), ultimately 
leading to an increase in dopamine (DA) in the nucleus accumbens (NAc), which is 
associated with drug reward and is common for all known drugs of abuse (Hendrickson, 
Guildford et al. 2013). Nicotine can activate VTA DAergic neurons directly by binding to 
and activating nicotinic acetylcholine receptors (nAChRs), pentameric ligand-gated 
cation channels normally activated by the endogenous neurotransmitter, acetylcholine 
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(ACh), while the mechanism by which alcohol activates these same neurons is complex 
and likely involves multiple neurotransmitter systems (Pidoplichko, DeBiasi et al. 1997, 
Xiao, Dong et al. 2008, Morikawa and Morrisett 2010, Theile, Morikawa et al. 2011, Liu, 
Zhao-Shea et al. 2012, Liu, Hendrickson et al. 2013).  
There are twelve known vertebrate genes encoding neuronal nAChR subunits, 
α2-10 and β2-4. Five subunits co-assemble to form functional receptors, with the 
majority of high affinity nAChRs heteromeric consisting of 2-3 α subunits coassembled 
with 2-3 β subunits (Zwart and Vijverberg 1998, Nelson, Kuryatov et al. 2003, Moroni, 
Zwart et al. 2006). 
Although not a direct agonist of nAChRs, ethanol can activate VTA DAergic 
neurons, in part, through increased release of ACh (Larsson, Edstrom et al. 2005), likely 
from cholinergic neurons of the lateral dorsal tegmentum (Oakman, Faris et al. 1995), 
which then leads to increased activation of VTA DAergic neurons via nAChRs 
(Blomqvist, Ericson et al. 1997, Larsson, Edstrom et al. 2005, Liu, Hendrickson et al. 
2013). In addition, ethanol can potentiate ACh-induced nAChR currents (Cardoso, 
Brozowski et al. 1999, Zuo, Kuryatov et al. 2002, Liu, Hendrickson et al. 2013), although 
the precise nAChR subtypes critical for ethanol activation of VTA DAergic neurons are 
unclear.  
Of particular interest, nAChRs containing the α6 subunit (α6* nAChR, * denotes 
the receptor complex contains additional, non-α6 subunits) are uniquely enriched in 
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catecholaminergic neurons including midbrain DAergic neurons where they are 
positioned to influence neuronal activity through cholinergic innervation (Champtiaux, 
Han et al. 2002, Champtiaux, Gotti et al. 2003, Drenan, Grady et al. 2008, Berry, Engle et 
al. 2015).  They also contribute to nicotine dependence-associated behavior including 
reward (Jackson, McIntosh et al. 2009, Gotti, Guiducci et al. 2010).  Given the 
relationship between nicotine and alcohol, it is not surprising that blocking  α6* nAChRs 
via an intra-VTA infusion of an α6, α3, β3* antagonist, α-conotoxin MII, reduces ethanol-
induced DA release in the nucleus accumbens, ethanol consumption, and ethanol 
reinforcement in rodents (Larsson, Jerlhag et al. 2004, Jerlhag, Grotli et al. 2006, 
Kuzmin, Jerlhag et al. 2009). Mice lacking chrna6, the gene encoding the α6 nAChR 
subunit (α6 knock-out (α6KO) mice), show a significant increase in the sedative effects 
of ethanol, taking significantly longer to regain their righting reflex following 4.1g/kg 
ethanol, but show no differences regarding ataxia with 1.5g/kg ethanol (Kamens, Hoft et 
al. 2012). These mice have also been studied with respect to ethanol consumption and, 
although they show no differences in ethanol consumption or preference in a two-bottle 
free-choice paradigm (Kamens, Hoft et al. 2012), their consumption during a binge-like 
drinking paradigm, which more closely resembles problematic drinking habits, has yet to 
be explored. Additionally, Powers et al. (2013) showed a potential role for α6* nAChRs 
in alcohol consumption and reward behaviors using a hypersensitive, transgenic mouse 
line, leading to the hypothesis that α6* nAChRs may be involved in these and other 
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alcohol-related behaviors. To address this hypothesis, we compared binge-like ethanol 
consumption and the rewarding properties of the drug in α6 KO mice and their wild-type 
(WT) littermates.    
Methods and Materials  
Animals 
8-20 weeks old α6 KO homozygous mice and their WT littermates were included in all 
experiments as indicated. This line was backcrossed to C57BL/6J at least 10 generations. 
The genetic engineering of this line has been described previously (Champtiaux, Han et 
al. 2002). α6 KO mice were bred homozygous x homozygous or heterozygous x 
heterozygous. Using Conditioned Place Preference as a representative experiment, mice 
from each breeding scheme were analyzed separately and then combined in all 
experiments as there was no significant difference between the two   groups (Male CPP 
2.0g/kg in Hom from Hom x Hom versus Het x Het [F(1,10)=0.02110, p=0.8874]). 
Animals were housed up to five per cage and kept on a 12-hour light/dark cycle prior to 
the start of each experiment. Mice had access to food and water ad libitum except where 
indicated. All experiments were conducted in accordance with the guidelines for care and 
use of laboratory animals provided by the National Research Council as well as with an 
approved animal protocol from the Institutional Animal Care and Use Committee of the 
University of Massachusetts Medical School. 
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Drinking-in-the-Dark (DID)  
For the binge-drinking assay, α6 KO and WT mice were moved from their colony room 
into a reverse light-dark room (lights ON at 8 PM and OFF at 8 AM) to habituate for two 
weeks prior to the start of the experiment. One week prior to the start of DID, mice were 
single-housed.  Three days before DID standard water bottles were replaced with bottles 
containing sipper tubes  with double ball bearing inserts to prevent leakage. In the DID 
assay, access to ethanol   was restricted to 2 h a day, beginning 2 hours into the dark 
cycle, for 4 days per week (Rhodes, Best et al. 2005). Water bottles were removed and 
replaced with pre-weighed ethanol bottles (50-mL conical tubes outfitted with a stopper 
and double ball bearing sipper tube) initially containing 2% ethanol in water (v/v) and 
increasing to 5%, 10%, and finally 20% over the course of 4 weeks. The ethanol bottles 
were removed, replaced with water bottles, and weighed after 2 h. Ethanol consumption 
was measured as grams ethanol per kilogram body weight mouse. Following the 4-week 
protocol, mice were given 10% sucrose and 10 mM saccharin for 2 hr on 2 consecutive 
days each as controls.   
Conditioned Place Preference (CPP)   
The CPP assay used was a 6-day protocol adapted from Gibb et al. (2011). The CPP 
apparatus (Med Associates, USA) consists of three distinct chambers, a small neutral, 
grey chamber flanked on each side by a larger conditioning chamber containing a wire 
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mesh floor and white walls and the other containing a metal rod floor and black walls. 
Each compartment contains photobeams used to monitor mouse movement in and out of 
each chamber, and the entire apparatus is contained in a sound-attenuating box with lights 
and a fan. On day 1, habituation day, α6 KO and WT mice were placed in the middle 
chamber and allowed free access into all three chambers for thirty minutes during the 
light phase of their light/dark cycle. Time spent in each chamber was monitored and 
recorded by Med PC software via photobeam breaks and used to determine any initial 
bias for either of the conditioning chambers. Mice spending more than 90% of their time 
in one chamber were excluded from the study. The least preferred chamber was set as the 
ethanol-paired chamber. On days 2-5, mice were given an i.p. injection of either saline or 
ethanol (balanced by sex, dose, treatment; dose as indicated; 20 % ethanol solution v/v), 
and were immediately confined to the corresponding chamber for five minutes. Mice 
were then returned to their home cage. Four to six h later, each mouse received the other 
injection (ethanol if they had saline in the morning, saline if they had ethanol) and were 
confined to the other chamber. Day 6 was the test day, and was the same protocol as day 
1. An increase in time spent in the ethanol-paired chamber on test day compared to the 
habituation day indicated reward.  
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Locomotor Activity  
Mice were given pre-injections of saline in their home cage for two days prior to 
initiation of the experiment. Locomotor activity was measured in α6 KO and WT mice 
using a cage rack photobeam system (PAS, San Diego Instruments) and the 
corresponding PAS software. Mice were placed in a novel cage within the locomotor 
apparatus, and ambulation (locomotion) was measured as the breaking of two distinct 
beams 10 cm apart. Locomotor activity was recorded on days 0, 1, 4, and 7, for one h, at 
which time mice were injected with saline (Day 0) or 2 g/kg ethanol (Days 1, 4, 7) 
(Martin, Hendrickson et al. 2008). Activity was recorded for an additional hour following 
the injection, and is presented in 5 minute bins immediately following the injection. Mice 
received home cage ethanol injections on days 2, 3, 5 and 6.  
Data Analysis 
Data were analyzed using One- or Two-way ANOVA followed by Bonferroni post-hoc 
tests or multiple comparison tests as indicated.  Results were considered significant at p < 
0.05.  All data are expressed as means ± SEM. 
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Results  
Expression of α6* nAChRs is not necessary for binge-like consumption of alcohol  
We used a restricted-access alcohol consumption assay,  drinking-in-the-dark (DID) 
(Rhodes, Best et al. 2005, Rhodes, Ford et al. 2007) to test whether α6* nAChRs play a 
role in binge-like alcohol consumption of 2 %, 5 %, 10 %, or 20 % ethanol (see Methods, 
Fig. 3.1) . A two-way ANOVA showed a significant effect of sex on ethanol consumption 
[F(1, 39) = 37.33, p < 0.0001], so males and females were separated for independent 
analysis. In both female and male mice,  two-way ANOVA revealed a significant main 
effect of ethanol concentration [F(3,78) = 326.3, p < 0.001 and F(3,96) = 463.9, p<0.0001, 
respectively], but not genotype [F(1,86) = 0.1781, p = 0.6764 and F(1,32) = 0.1770, p = 
0.6767, respectively, with no significant interaction (Fig. 3.1C, D). In addition, neither 
group exhibited a significant difference in sucrose or saccharin consumption (Fig. 3.1E, 
F). The absence of any effect of genotype on ethanol consumption indicates that 
expression of α6* nAChRs is not necessary for binge-like ethanol drinking.  
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Figure 3.1 Expression of α6* nAChRs is not necessary for binge-like ethanol 
consumption in the drinking-in-the-dark assay.  Daily consumption of 2-20 % ethanol 
during the DID binge-drinking assay in A) female and B) male WT and α6 KO mice. 
Average daily ethanol intake for each ethanol concentration for C) female (n=15 KO, 
n=19 WT) and D) male mice (n=14 KO, n=14 WT) of each genotype.   Average sucrose 
and saccharin consumption in E) female and F) male mice of each genotype. 
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Sex and 
Genotype
n Dose 
EtOH 
(g/kg)
SAL 
(Hab) 
(sec)
SAL 
(Test) 
(sec)
EtOH 
(Hab) 
(sec)
EtOH 
(Test) 
(sec)
Grey 
(Hab) 
(sec)
Grey 
(Test) 
(sec)
Male WT 6 0 681.1+ 
40.6
389.6 + 
41.7
576.7 + 
25.8
452.3 + 
73.7
542.2 + 
33.6
958.0 + 
106.1
9 0.5 650.8 + 
51.8
343.6 + 
34.9
494.5 + 
25.7
483.7 + 
86.3
654.7 + 
66.8
926.0 + 
112.5
10 2.0 696.2 + 
37.5
403.5 + 
72.7
513.1 + 
28.9
*722.4 + 
109.8
590.7 + 
28.9
674.1 + 
103.2
9 3.0 654.1 + 
33.4
397.5 + 
54.9
488.0 + 
24.8
**785.6 + 
86.5
673.3 + 
32.0
616.9 + 
61.8
Male 
α6KO 
7 0 647.6 + 
63.2
608.4 + 
43.3
414.5 + 
40.4
486.6 + 
56.9
737.9 + 
77.5
704.9 + 
80.6
6 0.5 573.5 + 
53.7
499.0 + 
96.1
504.3 + 
32.8
450.6 + 
87.3
722.2 + 
77.4
850.4 + 
178.2
9 2.0 661.3 + 
29.8
414.3 + 
79.5
439.8 + 
19.3
***820.5 + 
106.2
698.9 + 
28.2
565.1 + 
48.5
8 3.0 676.2 + 
34.3
484.8 + 
68.5
425.9 + 
38.7
580.8 + 
96.3
697.6 + 
62.9
734.4 + 
96.5
Female 
WT
9 0 630.6 + 
41.8
472.1 + 
65.8
542.7 + 
32.9
441.0 + 
81.3
626.7 + 
47.9
886.9 + 
77.4
10 0.5 640.8 + 
36.2
402.1 + 
49.5
460.4 + 
34.3
438.3 + 
79.0
698.8 + 
57.9
959.6 + 
106.1
10 2.0 709.1 + 
49.1
361.0 + 
58.5
540.6 + 
22.8
*855.5 + 
115.6
550.2 + 
52.5
583.5 + 
102.6
7 3.0 670.3 + 
35.5
407.6 + 
139.8
495.9 + 
28.9
*907.5 + 
146.1
633.8 + 
44.1
485.0 + 
56.9
Female 
α6KO
5 0 571.5 + 
39.7
533.6 + 
46.0
595.0 + 
65.6
391.4 + 
57.4
643.3 + 
79.5
874.9 + 
71.4
11 0.5 626.8 + 
32.1
480.7 + 
37.2
447.9 + 
30.5
599.8 + 
45.0
725.9 + 
41.9
719.4 + 
40.1
13 2.0 683.9 + 
28.3
516.4 + 
49.3
518.7 + 
27.7
**724.4 + 
57.0
597.4 + 
38.4
559.2 + 
51.5
6 3.0 627.0 + 
34.1
761.9 + 
107.9
600.9 + 
42.0
494.6 + 
76.3
572.1 + 
37.8
543.4 + 
74.0
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Table 3.1 Time spent in saline and ethanol-paired CPP chambers + SEM 
α6* nAChRs modulate reward response to high-dose ethanol  
 To test the hypothesis that  expression of α6* nAChRs is necessary for the 
rewarding effects of ethanol, we tested the ability of the drug to condition a place 
preference in female and male WT and α6 KO mice using the CPP assay at three distinct 
doses, 0.5 g/kg, 2.0 g/kg, and 3.0 g/kg ethanol, and with a saline injection (Fig. 3.2A, 
Table 3.1). Analysis of time spent in the ethanol-paired chamber on test day versus 
habituation day was done using successive two-way ANOVAs. Analysis of sex x ethanol 
dose indicated a significant effect of dose [F(3,121) = 14.40, p<0.0001], but not  
sex [F(1,121)=1.205, p=0.2722]. With sexes pooled, analysis of genotype x dose showed 
an effect of dose [F(3,127)=12.56, p<0.0001] and an interaction [F(3,127)=3.142, 
p=0.0276]. Post-hoc analysis revealed a statistically significant difference in time spent in 
the ethanol-paired chamber with 3.0g/kg in WT versus α6 KO animals. Together these 
data indicate that expression of α6* nAChRs is not absolutely required for ethanol 
reward, but modulates reward sensitivity of the drug. 
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α6* nAChRs are not necessary for ethanol-induced hypolocomotion  
 To test if ethanol-induced locomotor impairment differed between genotypes, we 
challenged female and male WT and α6 KO mice with an acute injection of saline (Day 
0) or 2.0 g/kg ethanol (Days 4 and 7) immediately prior to measuring locomotor activity. 
Two-way ANOVA  of sex x day revealed a main effect of day [F(3,69)=10.49, p<0.0001] 
but not sex [F(1,23)=0.2175, p=0.6453]. Genotype x day also showed only a significant 
effect of day [F(3,69)=10.97, p<0.0001], not genotype (Figure 3.2 B). These data suggest 
no significant role of α6* nAChRs in the locomotor response to ethanol, and no 
difference in the responses of the two sexes. 
 
Figure 3.2 Expression of α6* nAChRs modulate sensitivity to ethanol reward, but 
not ethanol-induced hypolocomotion. A. Time spent in the ethanol-paired chamber on 
the test day. Mice were conditioned with 0 g/kg (saline), 0.5 g/kg, 2.0 g/kg, or 3.0 g/kg 
ethanol.  n = 12-22 mice per genotype/dose (see Table 3.1 for specific n values), two-way 
ANOVA, Bonferroni post-hoc.  B. Average ambulation per 5 minute bin for 30 min 
following i.p. saline or 2.0g/kg ethanol (Days 1, 4, 7). n = 12 WT, n = 13 α6 KO. 
^compared to WT saline; #compared to α6 KO saline; *WT vs α6 KO; *p<0.5, **p<0.01, 
***p<0.001. 
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Discussion   
 The present study analyzed the contribution of α6* nAChRs in binge-like ethanol 
consumption and ethanol reward using a loss of function mouse model, the α6 KO line. 
Previously, this same mouse line was used to determine if α6* nAChR expression is 
involved in ethanol preference and consumption (Kamens, Hoft et al. 2012).  Using a 24 
hr two-bottle choice paradigm, Kamens et al. (Kamens, Hoft et al. 2012) found that α6 
KO mice consume and prefer ethanol similarly to their WT littermates.   However, binge-
like ethanol intake and reward was not analyzed.  Using the DID assay,  we also did not 
detect significant differences in ethanol consumption between α6 KO mice and their WT 
littermates at any ethanol dose tested in male or female mice, though overall females 
consumed significantly more ethanol than their male counterparts. In addition, ethanol 
was rewarding in α6 KO mice in that it could condition a place preference in these 
animals, but only at one dose (2.0g/kg), while a higher dose of ethanol (3.0g/kg) failed to 
condition a place preference, despite doing so in their WT littermates.  Thus, our data 
indicate that expression of α6* nAChRs is not necessary for ethanol consumption or 
reward per se, but these receptors do contribute to reward at high concentrations of 
ethanol.   
Interestingly, Powers et al. analyzed ethanol consumption and reward in a “gain-
of-function” bacterial artificial chromosome transgenic mouse line expressing α6 
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subunits harboring a point mutation (a leucine residue at the 9′ position mutated to a 
serine residue, the α6 L9′S line) that renders α6* nAChRs hypersensitive to ACh 
(Drenan, Grady et al. 2008, Powers, Broderick et al. 2013). These mice displayed an 
increase in ethanol consumption in both a two-bottle choice test and the DID assay 
compared to WT littermates.   In addition, mutant mice were more sensitive to the 
rewarding effects of ethanol (i.e. a sub-rewarding dose of ethanol conditioned a place 
preference in the mutant mice).  Because α6 L9′S mice are exquisitely sensitive to 
agonist, the increased ethanol consumption and leftward shift in ethanol reward 
sensitivity of these mice should be interpreted with caution. While the results obtained 
using the α6 L9′S mice implicate α6* nAChRs in regulating ethanol consumption and 
reward sensitivity, the impact of endogenous α6* receptors on ethanol behaviors in WT 
mice may be over-estimated.   
Similarly, there are caveats to our interpretations of ethanol behaviors in α6 KO 
mice.   In particular, compensatory expression of non-α6 nAChR subunits may occur in 
these animals in the absence of chrna6 expression, thereby minimizing any potential 
differences in ethanol consumption and reward between genotypes. In addition, α6 
nAChR subunits cannot form homomeric receptors; rather, they require at least one 
additional beta nAChR subunit (in particular β2 or β3) and also can coassemble with the 
α4 subunit especially in VTA DAergic neurons (Cui, Booker et al. 2003, Drenan, Grady 
et al. 2008, Zhao-Shea, Liu et al. 2011, Liu, Zhao-Shea et al. 2012, Engle, Shih et al. 
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2013).  Thus, in the absence of chrna6 expression, VTA DAergic neurons may express a 
greater number of nAChRs containing α4 subunits compared to WT mice, supported by 
the fact that the expression of α4, as measured by immunoprecipitation with epidatidine, 
increases in α6 KO animals (Champtiaux, Gotti et al. 2003).    As we  have previously 
identified a role for α4* nAChRs in ethanol behaviors, including reward and acute 
ethanol consumption, in males, increased α4* nAChRs in α6 KO mice may partially 
mask the contribution of α6* nAChRs in an α6 KO mouse background in males more 
than in females (Hendrickson, Zhao-Shea et al. 2010, Hendrickson, Gardner et al. 2011, 
Liu, Hendrickson et al. 2013). Although Champtiaux, Han et al. (2002) showed no such 
increase of this and other subunits in the VTA of α6 KO mice at the mRNA level, this 
was semi-quantitative and done using in situ hybridization;  compensation may still occur 
functionally or at the protein level, which could be uncovered via western blot analysis. 
An alternative approach to circumvent these caveats would be to knockdown α6* 
nAChRs in adult animals using small interfering RNAs (siRNAs), thereby allowing the 
animal to develop with the subunit and avoid many compensatory mechanisms that may 
occur in the knockout animals.  
 Despite the caveats described above, we did identify a decrease in expression of 
ethanol reward in α6 KO mice when challenged with a high ethanol dose (3.0g/kg).  This 
is consistent with previous data showing that ethanol-induced activation of VTA DAergic 
neurons is reduced in ex vivo midbrain slices from α6 KO mice compared to WT slices 
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(Liu, Zhao-Shea et al. 2013), although this was shown using 100mM ethanol, a 
concentration that may be different than that reached with a 3.0g/kg dose in a whole 
animal.  Additionally, Kamens et al. (2012) have shown that  α6  KO male and female 
mice show no differences in BEC, compared to WT, and no sex differences, when given 
3.0g/kg ethanol, making ethanol metabolism differences unlikely to have caused this 
result. Future studies using alternative approaches such as viral-mediated siRNA knock-
down of individual nAChR subunits in discreet brain regions of adult animals should be 
done to test contributions of nAChR subtypes in ethanol consumption and reward, as well 
as to identify if the key nAChRs involved in these behaviors are expressed in sub-
populations of VTA neurons, using a Cre-lox expression system and mouse lines with Cre 
expression driven by GAD or TH, for example. It may be, however, that a different brain 
region altogether is involved in the effects of α6* nAChRs on ethanol reward. These 
receptors, expressed on DAergic neurons and not GABAergic neurons in the VTA, are 
almost exclusively located on the terminals of these DAergic neurons, many of which 
project to the NAc. It may be that, in simply looking at the VTA, we are missing the main 
effect of α6* nAChRs in modulating release of DA in the NAc, or in the PFC, which also 
receives DAergic input from the VTA. To explore the site of DA action, we could use 
optogenetics to stimulate DAergic neurons within the VTA, using viral-delivery of cre-
dependent, channelrhodopsin in a TH-Cre mouse line, and measure DA levels in both the 
NAc and PFC via microdialysis. This would help pinpoint the important connections 
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made by VTA DAergic neurons. Once identified, DA release in the area following 
ethanol administration, including in α6 KO animals, could be explored further. By 
looking at the terminals in each of these areas, versus the cell bodies in the VTA, we may 
be more able to decipher the actions of ethanol via α6* nAChRs in the reward pathway.  
 Given that 2.0g/kg is the generally accepted rewarding dose of ethanol, and yet 
our results indicate a role for α6* nAChRs at 3.0g/kg, but not 2.0g/kg, it is important to 
consider the fact that this may be more complicated than simply a lack of reward at this 
high dose. It has also been previously shown that α6 KO mice are more sensitive to the 
sedative effects of ethanol, showing a greater latency to regain their righting reflex  in the 
loss of righting reflex (LORR) assay (Kamens, Hoft et al. 2012), but the same paper 
showed no effects on ataxia with. We saw no significant differences in the response of 
these mice to 2.0g/kg ethanol on any of the locomotor test days in either sex. This 
suggests little to no role of α6 in this hypolocomotor response to this dose of ethanol or in 
baseline locomotion, and consequently no locomotor impact on the CPP data. It may be 
that, as with reward, α6* nAChRs become important in higher doses of ethanol such as 
those used for our CPP and the aforementioned LORR (Kamens, Hoft et al. 2012), but 
this dose, being so close to the dose used for LORR, was not explored in this study.  
In conclusion, our data indicate that expression of α6* nAChRs is not necessary 
for binge-like ethanol consumption, but does modulate ethanol reward sensitivity at high 
doses.   
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CHAPTER IV: Nicotinic acetylcholine receptors and sex differences in 
ethanol behaviors 
Introduction  
  
 Nearly 38 million Americans experience problematic drinking, but only 1 in 6 
will speak to their healthcare provider regarding treatment (CDC 2016). Moreover, of 
those who do seek treatment, only about one-third will remain symptom free a year later 
(CDC 2016).  In order to successfully treat these patients, we first need an understanding 
of what alcohol actually does in the brain. We also need to consider that males and 
females may require different treatments. Human males tend to drink more than females, 
and are more likely to meet abuse and dependence criteria, but females who do use 
alcohol tend to move more quickly from use to abuse than do their male counterparts 
(Nolen-Hoeksema and Hilt 2006). These difference could be due to social perceptions of 
acceptable drinking, with male alcohol abuse tending to be viewed less harshly than 
female, or it could be due to genetic or hormonal differences between the two sexes 
(Nolen-Hoeksema and Hilt 2006). In rodents, females tend to drink more than the males 
(Barker, Torregrossa et al. 2010, Lenz, Muller et al. 2012, Becker and Koob 2016, Carroll 
and Lynch 2016), which, although opposite to the human pattern, still suggests the sex 
differences may be biological rather than societal.  
 The frequent co-abuse of alcohol and nicotine, with an estimated 70-75% of 
alcoholics also identifying as tobacco-dependent (Miller and Gold, 1998), suggests a 
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common mechanism of the two drugs. Nicotine and alcohol both activate dopaminergic 
(DAergic) neurons of the ventral tegmental area (VTA), ultimately leading to an increase 
in dopamine (DA) release in the nucleus accumbens (NAc), which is associated with drug 
reward and is common for all known drugs of abuse (Pidoplichko, DeBiasi et al. 1997, 
Rodd, Melendez et al. 2004, Tsai, Zhang et al. 2009). Nicotine activates these VTA 
DAergic neurons by binding to and activating nicotinic acetylcholine receptors (nAChRs) 
on these neurons (Pidoplichko, DeBiasi et al. 1997, Maskos, Molles et al. 2005), but the 
mechanism by which alcohol activates these VTA DAergic neurons is as yet unknown.  
  Neuronal nAChRs are pentameric ligand-gated cation channels that are activated 
endogenously by acetylcholine (ACh) as well as by exogenous nicotine, the active 
ingredient in tobacco (Tapper, McKinney et al. 2004, Albuquerque, Pereira et al. 2009). 
There are twelve known vertebrate genes encoding neuronal nAChR subunits α2-10 and 
β2-4. Five subunits co-assemble to form functional receptors (Laviolette and van der 
Kooy 2004, Albuquerque, Pereira et al. 2009), most of which are heteromeric and consist 
of 2-3 α and 2-3 β subunits (Zwart and Vijverberg 1998, Nelson, Kuryatov et al. 2003, 
Moroni, Zwart et al. 2006, Dani and Bertrand 2007). Heteromeric receptors display high 
affinity for agonist, while homomeric receptors, formed only by α subunits, show low 
affinity (Buisson and Bertrand 2001, Nelson, Kuryatov et al. 2003, Moroni, Zwart et al. 
2006, Albuquerque, Pereira et al. 2009). The biophysical and pharmacological properties 
of the receptor depend on the subunits that make up the receptor, also known as the 
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receptor subtype (McGehee and Role 1995, Buisson and Bertrand 2001, Nelson, 
Kuryatov et al. 2003, Moroni, Zwart et al. 2006, Gotti, Moretti et al. 2007, Gotti, 
Guiducci et al. 2010).  
 Previously, it has been shown that the activation of VTA DAergic neurons occurs 
via α4-containing (α*) nAChRs for both nicotine (Tapper, McKinney et al. 2004) and 
alcohol (Liu, Hendrickson et al. 2013), with a contribution of α6* nAChRs as well (Liu, 
Zhao-Shea et al. 2012, Liu, Zhao-Shea et al. 2013, Guildford, Sacino et al. 2016). 
Interestingly, male alcohol reward is also α4* nAChR-dependent, as our lab has shown 
that α4 knock out (α4KO) male mice show no alcohol reward at the generally accepted 
rewarding dose of 2.0g/kg while their wild type (WT) littermates do (Liu, Hendrickson et 
al. 2013). α4 and α6 are both enriched in the VTA (Champtiaux, Han et al. 2002, 
Champtiaux, Gotti et al. 2003, Pons, Fattore et al. 2008, Liu, Hendrickson et al. 2013, 
Liu, Zhao-Shea et al. 2013), which is one of only a few regions of the brain that contain 
α6 (Champtiaux, Han et al. 2002, Gotti, Guiducci et al. 2010), and these subunits 
frequently co-assemble to make α4α6* nAChRs in this area (Champtiaux, Han et al. 
2002, Champtiaux, Gotti et al. 2003, Liu, Hendrickson et al. 2013, Liu, Zhao-Shea et al. 
2013). Both α4 and α6 mRNA are higher in VTA DA neurons activated following 
systemic ethanol than those not activated (Hendrickson, Zhao-Shea et al. 2010), and 
intra-VTA infusion of an α6*, α3*, β3* antagonist, α-conotoxin MII, reduces ethanol-
induced DA release in the nucleus accumbens, ethanol consumption, and ethanol 
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reinforcement in rodents (Larsson, Jerlhag et al. 2004, Jerlhag, Grotli et al. 2006, 
Kuzmin, Jerlhag et al. 2009). Powers et al. (2013) showed a potential role for α6* 
nAChRs in alcohol behaviors using a hypersensitive, transgenic mouse line, leading to 
the hypothesis that α6* nAChRs may be involved in these and other alcohol-related 
behaviors, although we found this to be the case only with a high dose of ethanol with no 
significant sex differences (Guildford, Sacino et al. 2016).  
 We sought to explore any potential gender-specific nAChR contributions, by 
examining several alcohol behaviors, including binge drinking, alcohol reward, alcohol-
influenced locomotor activity, as well as alcohol-induced activation of the reward 
pathway in males and females. Various behaviors are associated with alcohol use, but 
drinking patterns, quantity, and degree of euphoria or reward experienced have been 
shown in humans to be critical factors in the progression from alcohol abuse to alcohol 
dependence (Dani and Harris 2005, WHO 2015), making it imperative to decipher the 
mechanisms behind these behaviors in order to develop more targeted and ultimately 
more successful therapeutics for AUDs.  
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Methods and Materials  
Animals 
8-20 weeks old α4- or α6- knockout (KO) homozygous mice and their wild-type 
littermates (WT), males and females, were used in all experiments as indicated. The two 
lines were individually backcrossed to C57BL/6J at least 10 generations. The engineering 
of the α4 KO line has been described in (Tapper, McKinney et al. 2004), while the α6 KO 
line was described by Champtiaux et al. (2002). Animals were housed up to five per cage 
and kept on a 12-hour light/dark cycle prior to the start of each experiment. Mice had 
access to food and water ad libitum except where indicated. All experiments were 
conducted in accordance with the guidelines for care and use of laboratory animals 
provided by the National Research Council as well as with an approved animal protocol 
from the Institutional Animal Care and Use Committee of the University of 
Massachusetts Medical School. 
  
Drinking-in-the-Dark 
For the binge-drinking assay (Rhodes, Best et al. 2005), mice were moved from their 
colony room into a reverse light-dark room (lights ON at 8PM and OFF at 8PM) to 
habituate for two weeks prior to the start of the experiment. One week before the 
experiment, mice were single-housed, and three days before the experiment, mice were 
given water bottles with the same sipper tube setup (double ball bearing) as the 
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experimental tubes to habituate. The drinking-in-the-dark (DID) assay was run 2 hours a 
day, starting 2 hours into the dark cycle, and 4 days a week. Water bottles were removed 
and replaced with pre-weighed 50-mL conical tubes outfitted with a stopper and double 
ball bearing sipper tube. This tube contained an ethanol solution, starting at 2% ethanol in 
water (v/v) and increasing to 5%, 10%, and finally 20% over the course of 4 weeks, with 
3 days ethanol-free between each dose. This tube was removed and weighed after 2 
hours, and the water bottles were replaced. Ethanol consumption was measured as grams 
ethanol per kilogram body weight of the mouse. Following the 4-week protocol, mice 
were given 10% sucrose and 10mM saccharin for 2 days each as controls.   
  
Conditioned Place Preference  
The conditioned place preference (CPP) assay used was a 6-day protocol adapted from 
Gibb et al. (2011) and is described previously (Liu, Hendrickson et al. 2013, Guildford, 
Sacino et al. 2016). On day 1, habituation day,  mice were placed in the middle chamber 
and allowed free access into all three chambers. There was no injection on the habituation 
day. Time spent in each chamber was monitored and recorded by the associated software 
via photobeam breaks and used to determine any initial bias for either of the conditioning 
chambers. On days 2-5, mice were given an i.p. injection of either saline or ethanol 
(balanced, dose as indicated, 20% ethanol solution v/v), and were immediately confined 
to the corresponding chamber for five minutes. Mice were then returned to their home 
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cage. Four to six hours later, each mouse received the other injection (ethanol if they’d 
had saline in the morning, saline if they’d had ethanol) and were confined to the other 
chamber. Day 6 was the test day, and was the same protocol as day 1. An increase in time 
spent in the ethanol-paired chamber on test day compared to the habituation day indicated 
reward.  
  
Locomotor Activity  
Mice were given pre-injections of saline in their home cage for two days prior to 
initiation of the experiment. Locomotor activity was measured as previously described 
(Guildford, Sacino et al. 2016) and was recorded on days 0, 1, 4, and 7, for one hour, at 
which time mice were injected with saline (Day 0) or 2g/kg ethanol (Days 1, 4, 7). 
Activity was recorded for an additional hour following the injection, and is presented in 5 
minute bins beginning 5 minutes after initiation of the experiment and 5 minutes after the 
injection. 
  
Immunofluorescence   
Mice were i.p. injected with saline for 3 days prior to the experiment to habituate to 
injections and reduce any stress-induced c-fos. On the day of the experiment, mice were 
given an i.p. injection of saline or either 2.0g/kg or 3.0g/kg ethanol. Ninety minutes later, 
the mice were given an i.p. injection of pentobarbital (200mg/kg), were transcardially 
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perfused, and their brains were harvested as previously described (Liu, Hendrickson et al. 
2013). Following a 2-hour post-fix in 4% paraformaldehyde and subsequent equilibration 
in 30% sucrose, the brains were sliced at 25µm, and the VTA slices were collected. 
These slices were then stained using antibodies for tyrosine hydroxylase (TH) and c-fos, 
mounted, and viewed using a fluorescence microscope (Carl Zeiss MicroImaging Inc.). 
Neurons were considered positive (+) if the signal intensity was at least double that of 
background. TH+/c-fos+ neurons, as well as TH-/c-fos+ neurons, from 5 VTA slices from 
each mouse were counted, and the average number per slice was recorded.  The 
experimenter was blind to the drug treatment.   
Results  
CPP and DID  
 α4* nAChRs play different role in male and female binge-drinking and reward  
As we have previously shown, the α4 subunit is critical for alcohol reward in male mice 
(Liu, Hendrickson et al. 2013). Here, we used the same CPP paradigm to study ethanol 
reward in female mice, including Leu9’Ala heterozygous, α4KO, and WT mice.  Each 
genotype and dose was compared to its own habituation (data not shown), with a 
significant increase in time spent on test day compared to habituation used as a measure 
of reward (Figure 4.1A). Female Leu9’Ala heterozygous mice displayed a significant 
main effect of day (habituation versus test) [F(1,18) = 6.822, p = 0.0177], but not ethanol 
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dose [F(3,18) = 2.177, p = 0.1261], nor any significant interaction between the two 
[F(3,18) = 2.174, p = 0.1264]. Female WT show no significant main effect of day 
[F(1,29) = 0.2932, p = 0.5922], dose [F(3,29) = 2.762, p = 0.0599], and no interaction 
between the two [F(3,29) = 2.389, p = 0.0892]. Female α4 KO also show no significant 
main effect of day [F(1, 33) = 4.079, p = 0.0516] or dose [F(3,33) = 2.135, p = 0.1146], 
but do show a significant interaction [F(3,33) = 3.26, p = 0.0337] indicative of a 
conditioned place preference at 3.0g/kg (Sidak’s multiple comparisons test post hoc). 
This is in stark contrast to males, where Leu9’Ala males condition a place preference at 
0.5g/kg ethanol, WT males condition a place preference at 2.0g/kg ethanol, and α4 KO 
males show no CPP at any dose observed (Liu, Hendrickson et al. 2013). For this study, 
0.5g/kg and 3.0g/kg were studied, and α4 KO showed no significant main effect of day 
[F(1,15) = 0.01871, p = 0.8930], dose [F(2,15) = 0.2218, p = 0.8037], or interaction 
between the two [F(2,15) = 0.2724), p = 0.7652] (unpublished MGD) (Figure 4.1B).  
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Figure 4.1 α4* nAChRs are critical for ethanol reward only in males. Time spent in 
ethanol-paired chamber on test day in females (A, n=3-14) and males (B, n=3=18) shown 
with SEM. Unpublished data for females and males (doses 0.25 and 3.0 only, others 
previously published in Hendrickson et al. 2013). Two-way ANOVA with Sidak’s 
multiple comparisons test. *p< 0.05 compared to own habituation time, not shown.  
  
 In addition to the reward data, we have also shown that α4KO males drink less 
20% ethanol than WT (Hendrickson, Zhao-Shea et al. 2009). In this experiment, the mice 
had also received injections of saline prior to intake studies. In the current study, we 
expanded upon these results. Using the DID assay, we measured ethanol intake using 2, 
5, 10, and 20% ethanol, with each concentration being administered for 4 days followed 
by 3 days with no ethanol. Males showed a significant main effect of ethanol 
concentration [F(3,60) = 86.76, p < 0.0001], genotype [F(1,60) = 36.32, p < 0.0001], and 
an interaction of concentration x genotype [F(3,60) = 8.782, p < 0.0001], and α4 KO 
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mice consumed significantly less 10% and 20% ethanol than WT [Bonferroni’s multiple 
comparisons test post hoc], as well as a decrease in saccharin consumption. (Figure 4.2 
D-F). Females displayed a significant main effect of concentration [F(3,36) = 54.73, p < 
0.0001], but not genotype [F(1,36) = 0.2723, p = 0.2723] nor any interaction [F(3,36) = 
0.2105, p = 0.8885], and α4KO mice did not differ from WT females in their ethanol 
intake at any concentration. (Figure 4.2 A-C). The consumption data suggest that α4* 
nAChRs may be involved in male, but not female, binge-drinking, and, although the role 
of α4* nAChRs in ethanol reward in females is unclear, is it different than the role played 
in male ethanol reward.  
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Figure 4.2 α4* nAChRs are involved in ethanol consumption only in males. A. 
Female WT and α4 KO consume the same amount of ethanol on each day of drinking 
(top panel) and averaged across the four drinking days (middle panel). B. Male α4 KO 
consume significantly less 10% and 20% ethanol on individual days (top panel, multiple 
t-tests) as well as averaged across the drinking days (middle panel, two way ANOVA 
with Bonferonni’s multiple comparisons test).  *p<0.05 
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α6* nAChRs may modulate reward response to high-dose alcohol in males and females 
 Powers et al. (2013), in addition to their ethanol consumption data, showed a role 
for α6* nAChRs in alcohol reward using the previously mentioned α6 L9’S mouse line. 
Results of α6KO and WT CPP were published previously (Guildford, Sacino et al. 2016) 
and presented in Chapter III with the sexes combined as no significant sex differences 
were observed. These data are presented separately by sex below to display potential sex 
differences more clearly.  
 Female WT mice show a significant main effect of dose [F(3,32) = 6.303, p = 
0.0018], day [F(1,32) = 7.248, p = 0.0112], and an interaction [F(3,32) = 4.862, p = 
0.0067], and show CPP at 2.0g/kg and 3.0g/kg (Sidak’s multiple comparisons test post 
hoc). α6 KO females also show a significant interaction between dose and day [F(3,31) = 
6.891, p = 0.0011], though no main effect of either individually [F(3,31) = 2.733, p = 
0.0605; F(1,31) = 0.1554, p = 0.6962, respectively]. Post hoc analysis showed a 
significant CPP at 2.0g/kg ethanol only (Figure 4.3A). In males, WT show a significant 
effect of day [F(1,30) = 8.071, p = 0.0080] but not dose [F(3,30) = 1.689, p = 0.1903], 
and a significant interaction [F(3,30) = 5.389, p = 0.0044]. Sidak’s multiple comparisons 
test shows a significant CPP at 2.0g/kg and 3.0g/kg ethanol, similar to WT females.  α6 
KO males also display a significant main effect of day [F(1,26) = 10.74, p = 0.0030), but 
not dose [F(3,26) = 2.198, p = 0.1123], as well as a significant interaction [F(3,26) = 
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4.881, p = 0.0080], and a CPP at 2.0g/kg but not 3.0g/kg (Sidak’s multiple comparisons 
test post hoc).  
Females      Males  
Figure 4.3 α6* nAChRs modulate ethanol reward sensitivity in females and males. 
WT and α6 KO females (A) and males (B) condition a place preference to 2.0 g/kg 
ethanol, and WT of both show CPP at 3.0g/kg, which is abolished in KO. (Data 
previously published in Guildford et al. 2016 with sexes combined.) (Two-way ANOVA 
with Bonferonngi’s multiple comparisons test *p <0.05 compared to own habituation 
time, which is not shown)  
Locomotor Activity 
 No differences in locomotor activity between α6KO and WT 
 There were no differences in baseline locomotor activity between genotypes at 
any point measured (Multiple t-tests, p > 0.7 in all cases) in either sex.    (Figure 4.4).  
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Figure 4.4 No difference in locomotor response to ethanol between WT and α6 KO. 
WT and α6 KO females (n=5-6) (A) and males (n=7) (B) show no difference in baseline 
locomotor activity. 
Immunofluorescence 
 Alcohol-induced activation of VTA is blunted in female α4KO  
 Using c-fos as a marker for neuronal activation and tyrosine hydroxylase as a 
marker of dopaminergic neurons, we have previously shown that α4* nAChRs are 
critically involved in alcohol-induced activation of VTA DAergic neurons in male mice 
(Liu, Hendrickson et al. 2013). In order to assess any sex differences in the role of this 
receptor subtype, we administered saline or 2.0 g/kg or 3.0g/kg ethanol via i.p. injection 
to α4KO and WT mice female. We then sectioned the VTA and stained for c-fos and TH, 
with c-fos/TH double positive cells indicating activated dopaminergic neurons. We 
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focused on the pVTA, as previous studies have shown that this sub-region is especially 
important for alcohol-induced activation (Hendrickson, Zhao-Shea et al. 2009, 
Hendrickson, Zhao-Shea et al. 2010, Liu, Hendrickson et al. 2013, Liu, Zhao-Shea et al. 
2013). Whereas male α4KO mice show no increase in c-fos activation in VTA DAergic 
neurons following 2.0g/kg ethanol (i.p.) while WT show a significant increase (Liu, 
Hendrickson et al. 2013). Females show a significant main effect of treatment [F(1,27) = 
18.23, p = 0.0002], but not of genotype [F(1,27) = 2.857, p = 0.1025] and no interaction 
[F(1,27) = 1.995, p = 0.1693] (Figure 4.5 A-C).  This suggests any role for α4* nAChRs 
in this activation in females is small and non-critical. 
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Figure 4.5 α4* nAChRs play  a role  in ethanol-induced VTA activation, but is not 
critical in females.  A. WT females given i.p. ethanol (2.0g/kg) show increased c-Fos in 
TH positive neurons compared to saline. B. α4 KO females show a blunted  increase in 
c-Fos. Results quantified in C. ** p < 0.01 two-way ANOVA with Tukey’s multiple 
comparisons test.  
α6* nAChRs modulate activation of VTA  
  In addition to the involvement of α4* nAChRs, we have also shown that the 
neurons that are activated following ethanol administration have higher α4 and α6 mRNA 
than those not activated following ethanol, suggesting a potential role for α6 as well in 
this activation (Hendrickson, Zhao-Shea et al. 2010). Therefore, we used the same 
protocol to assess ethanol-induced c-fos activation in α6 KO mice.  
 Male mice from the α6 line show a significant main effect of treatment [F(2,26) = 
17.58, p < 0.0001], but not of genotype [F(1,26) = 2.488, p = 0.1268] nor a significant 
interaction [F(2,26) = 1.36, p = 0.2744] (Figure 4.6 C,D). In females, similarly to males, 
there is a significant main effect of treatment [F(2,28) = 7.24, p = 0.0029], but not 
genotype [F(1,28) = 0.3507, p = 0.5584], and no interaction [F(2,28) = 1.159, p = 0.3285] 
(Figure 4.6 A,B). Given these results, the genotypes were pooled within each sex to 
investigate the sex difference independent of the genotype. With 2.0g/kg ethanol, 
compared to saline, there is a significant main effect of treatment [F(1,37) = 44.36, p < 
0.0001], but not genotype [F(1,37) = 4.027, p = 0.0521], and a significant treatment x 
genotype interaction [F(1,37) = 6.387, p = 0.0159]. Tukey’s multiple comparisons test 
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show a significant increase in males and in females at 2.0g/kg ethanol, as well as a 
significant difference between male activation and female activation at this dose (male > 
female). At 3.0g/kg ethanol, only the significant effect of treatment remains [F(1,42) = 
29.53, p < 0.0001], with no effect of genotype [F(1,42) = 0.3127, p = 0.5790] and no 
interaction [F(1,42) = 0.01303, p = 0.9097].  
          
A.   Saline    2g/kg   3.0g/kg  
 
WT 
α6KO 
B.   
WT α6KO
0.0
0.5
1.0
1.5
2.0
2.5
Av
g 
N
um
be
r o
f 
TH
+/
c-
fo
s+
 n
eu
ro
ns
 
Average TH+/c-fos+ per slice - Females
Saline
2g/kg Ethanol 
3g/kg Ethanol 
**
!94
C.       Saline         2.0g/kg          3.0g/kg  
 
D. 
Figure 4.6 α6* nAChRs do not play a role in ethanol-induced activation in females, 
may play role in males. A. Female WT show increased c-Fos in TH+ neurons of the 
VTA following 3.0g/kg ethanol, as do α6 KO. Quantified in B. C. Male WT show 
increased c-Fos in TH+ neurons following 2.0g/kg, but α6 KO males show a blunted 
response at this dose. Quantified in D. *p < 0.05, ** p < 0.01 two-way ANOVA and 
Tukey’s multiple comparison’s test.  
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Discussion 
 The frequent co-abuse of alcohol and nicotine suggest a common neural 
mechanism of action of these two drugs. We have previously shown that α4* nAChRs 
play a critical role in ethanol reward and ethanol-induced activation of the dopamine 
reward pathway in males (Liu, Hendrickson et al. 2013), and that DAergic neurons 
activated following ethanol administration have higher α4, α6, and β3 mRNA than those 
not activated (Hendrickson, Zhao-Shea et al. 2010), suggesting a role for these receptor 
subunits in the effects of ethanol. In order to develop successful treatments for problem 
drinking, as well as alcohol dependence and addiction, we first need to understand the 
way in which ethanol acts both in the brain and in shaping behavior. Drinking patterns, 
quantity, and degree of euphoria experienced have been shown in humans to be critical 
factors in the progression from alcohol abuse to alcohol dependence (Dani and Harris 
2005, WHO 2015), and uncovering the factors influencing these behaviors is an 
important step in understanding the progression of harmful alcohol use.  
 Humans and rodents both show sex differences in alcohol consumption (Lancaster 
1995, Middaugh and Kelley 1999, Nolen-Hoeksema and Hilt 2006), which may be due to 
differences in the mechanisms underlying consumption and other ethanol-related 
behaviors. In humans, males tend to drink more ethanol and are more likely to meet 
criteria for alcohol dependence than females, although females tend to move from alcohol 
use to abuse more quickly than males (Nolen-Hoeksema and Hilt 2006). In rodents, sex 
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differences manifest differently, with females consuming more alcohol than their male 
counterparts (Lancaster 1995, Middaugh, Kelley et al. 1999). In our previous studies, we 
have shown that male mice lacking α4* nAChRs consume less 20% ethanol than their 
WT littermates following saline injections (Hendrickson, Zhao-Shea et al. 2010), and that 
the α4* nAChR partial agonist Varenicline (Chantix®) reduced drinking in WT males, 
but not α4KO males. Using the same DID protocol, we saw reduced consumption of 10% 
and 20% ethanol in males (Figure 4.2 D-F), and no difference in ethanol consumption 
between α4KO and WT females at any ethanol concentration (Figure 4.2 A-C). In order 
to ensure any ethanol consumption differences were specific to ethanol, we used 10% 
sucrose and 10 mM saccharin as caloric and taste controls, respectively. α4KO males 
consumed the same amount of sucrose as WT, but less saccharin (Figure 4.2 F). This 
could be due to an overall reduced amount of drinking, as, although not significant, 
α4KO males showed a trend toward reduced sucrose intake, but given the similar 
consumption of 2% and 5% ethanol solutions between the two genotypes, this may not be 
due to simple hypodipsia. Anhedonia could account for the decrease in ethanol and 
saccharin, as could a general reward dysfunction. Females showed no differences in 
consumption of either control solution between α4KO and WT.  
 Unlike WT, α4KO males do not condition a place preference to the rewarding 
dose of ethanol, 2.0 g/kg (Liu, Hendrickson et al. 2013). Using the CPP assay, we found 
that only α4KO females condition a place preference to 3.0 g/kg, with no significant CPP 
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at any dose in WT females (Figure 4.1A). This could be a result of a rightward shift in 
the dose response curve in α4KO females compared to WT, although in that case I would 
expect a CPP at a lower dose in WT females. There could be a difference in metabolism 
between the two genotypes, or perhaps the estrous cycle causing differences in ethanol 
reward. These could be explored by assessing blood-ethanol concentrations (BEC) and 
monitoring the estrous cycles of the females, respectively.  
 Given the role for α4* nAChRs in ethanol behaviors in males (Hendrickson, 
Zhao-Shea et al. 2010, Liu, Hendrickson et al. 2013), and the less clear results in females, 
it is tempting to speculate that perhaps a different subtype of nAChR may be important in 
females. The α6 subunit is present in only a few brain regions, including the mesolimbic 
dopaminergic pathway, which highlights the potential importance of this subunit in these 
regions (Le Novere, Zoli et al. 1996, Champtiaux, Han et al. 2002, Drenan, Grady et al. 
2008). Liu et al. (2013) showed that ethanol-induced activation of VTA DAergic neurons 
in vitro may involve α6* nAChRs, a subunit known to co-assemble with α4 (Champtiaux, 
Han et al. 2002, Champtiaux, Gotti et al. 2003, Liu, Hendrickson et al. 2013, Liu, Zhao-
Shea et al. 2013), and Hendrickson et al. (2010) showed elevated mRNA of both α4 and 
α6 in ethanol-activated VTA DAergic neurons. Additionally, α6KO male and female mice 
are more sensitive to the sedative effects of ethanol than WT (Kamens, Hoft et al. 2012), 
although the same study also found no differences in ethanol consumption in these mice. 
Pharmacological blockade of VTA α6* nAChRs, using the antagonist α-conotoxin MII, 
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reduces ethanol reward (Larsson, Jerlhag et al. 2004), and it has recently been shown that 
male and female mice with hypersensitive α6* nAChRs show increased ethanol 
consumption and sensitivity to ethanol reward. These data make α6* nAChRs good 
candidates for involvement in ethanol behaviors, especially in females, and perhaps in 
concert with the α4 subunit.    
 Using the DID binge-like drinking assay, I explored the role of α6* nAChRs in 
ethanol consumption. I saw no difference between α6KO mice and their WT littermates 
at any ethanol dose, in males or females (Figure 4.4). This suggests little to no role of 
α6* nAChRs in this behavior. Powers et al. (2013), however, found a role for α6* 
nAChRs using a mouse line containing a hypersensitive α6 subunit. The discrepancy in 
results could be due to procedural differences or to effects of the genetic changes on the 
receptors themselves. For example, α6KO mice may display functional compensation by 
other subunits. Similarly, a hypersensitive α6 subunit may not necessarily portray a 
physiological phenomenon accurately. These caveats could be ameliorated by using 
optogenetics (Wang, Szobota et al. 2007) to silence neurons containing α6* nAChRs 
during behavioral assays, minimizing the effects of developing without the subunit. 
 We also looked at the role of α6* nAChRs in ethanol reward using conditioned 
place preference. Given previous results of higher α6 mRNA in ethanol-activated 
DAergic VTA neurons (Hendrickson, Zhao-Shea et al. 2010) and hypersensitive L9’S 
mice showing CPP at a sub-rewarding dose of ethanol (Powers, Broderick et al. 2013), 
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we hypothesized that our α6 KO mice would show reduced CPP compared to WT. We 
previously presented α6 KO CPP results (Guildford, Sacino et al. 2016), with the sexes 
combined, but have separated them out here to assess any sex differences.  The generally 
accepted rewarding dose of ethanol is 2.0 g/kg, and this dose elicited a CPP from WT 
males and females, as well as α6KO males and females (Figure 4.3). A CPP is indicative 
of reward, and thus it seems, at this dose, α6 may not play an important role. However, at 
3.0 g/kg, the male and female WT, but not α6 KO, mice showed a CPP. This suggests a 
role for α6* nAChRs at higher doses of ethanol or alternatively, a slight leftward shift in 
the ethanol response, making 3.0 g/kg potentially aversive to the α6 KO animals. Powers 
et al. (2013) showed L9’S mice condition a place preference at 0.5 g/kg ethanol, a dose 
which did not show a CPP in WT mice or α6 KO mice, but, were unable to elicit a CPP in 
WT animals at 2.0 g/kg ethanol. This suggests some role for α6* nAChRs, though it 
would be expected that a hypersensitive receptor would act in the opposite manner to that 
of a knocked out receptor. Procedural differences, for example training sessions done on 
alternating days (saline one, ethanol the next etc.) for a total of 10 days, versus ours with 
both done each day, 6 hours apart, for 4 days, may account for the different results. It 
could also be the case that these L9’S α6* nAChRs, or those with the α6 subunit knocked 
out during development, act differently than physiologically normal receptors.  
 α4* nAChRs play little to no role in female ethanol consumption and reward, 
unlike their male counterparts (Liu, Hendrickson et al. 2013), exposing a gender 
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difference in the way in which mice respond to ethanol. It is important to consider that 
this gender difference may translate to humans as well, given that current research 
focuses mainly on males. α6* nAChRs, unlike α4* nAChRs, may play a role in ethanol 
reward at high ethanol doses (3.0 g/kg) in both males and females, but these receptors are 
not necessary for alcohol reward at 2.0 g/kg, the generally accepting rewarding dose.  
 The VTA is a central part of the mesolimbic dopamine reward pathway, and has 
been shown to be activated following ethanol administration (Blomqvist, Ericson et al. 
1997, Larsson, Edstrom et al. 2005, Hendrickson, Zhao-Shea et al. 2010, Liu, 
Hendrickson et al. 2013, Liu, Zhao-Shea et al. 2013). We have also previously shown a 
crucial role for α4* nAChRs in activation of the DAergic neurons of this area following 
ethanol, wherein α4 KO male mice show no increase in c-fos activation following 2.0 g/
kg ethanol, while WT littermates show a significant increase (Liu, Hendrickson et al. 
2013). Here, we have shown that this role is different in females, as there is no significant 
interaction between genotype and treatment, although the response in α4 KO females 
appears blunted compared to WT (Figure 4.5 A-C).  
 Given the propensity of α4 subunits to co-assemble with α6 in the VTA, and the 
potential role of α6* nAChRs in in vitro activation of VTA DAergic neurons with ethanol 
(Liu, Zhao-Shea et al. 2013), we explored in vivo activation of these neurons using c-fos 
as a marker of neuronal activation. Following systemic ethanol (2.0 g/kg and 3.0 g/kg), 
WT males showed a significant increase in c-fos in TH-positive neurons compared to 
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saline controls, indicating and increase in activation of VTA DAergic neurons with 
ethanol (Figure 4.6 C,D). α6KO males also showed this activation pattern, indicating no 
effect of a lack of α6* nAChRs in ethanol-induced activation in these animals. Similarly, 
there was no difference in alcohol-induced activation in WT and α6 KO females; both 
showed increased c-fos in VTA DAergic neurons following 2.0g/kg and 3.0g/kg ethanol 
(Figure 4.6 A,B).  Liu et al. (2013) showed a role for α6* nAChRs in ethanol-induced 
activation of VTA DAergic neurons, but those studies were done in vitro via 
electrophysiology, in which afferents and efferents are not all intact, using higher ethanol 
concentrations than those occurring physiologically and are not easily translated into a g/
kg dose. In addition, the ethanol was directly applied to the VTA, whereas in vivo, the 
ethanol is given i.p. and metabolized. This method of ethanol delivery is more 
physiologically relevant than ethanol being directly infused onto the VTA, although there 
are even more relevant delivery mechanisms than those used in this study, for example 
gavage. Additionally, those results did not differentiate between males and females, 
which, as we have shown in this study, have differences in activation of the VTA 
following ethanol administration.  
 Interestingly, there is a disconnect between activation of the VTA DAergic 
neurons as measured by c-fos activation, and the expression of ethanol reward, measured 
by CPP. While both genotypes and sexes show c-fos activation following 2.0 and 3.0 g/kg 
ethanol, α6 KO males and females show no CPP at 3.0 g/kg while their WT counterparts 
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do. This suggests that activation of these neurons is not necessarily directly related to the 
expression of CPP. It may be that at the higher dose of ethanol, versus the rewarding dose 
of 2.0g/kg, a different neuronal subtype, such as GABAergic neurons, may be involved in 
the expression of CPP. Although, with α6* nAChRs expressed only on DAergic, and not 
GABAergic, neurons in the VTA, it is unlikely to be the case here. The Koobian model of 
addiction suggests there exists not only a reward pathway, but an anti-reward pathway, 
involved in the adaptive processes to restore normal function in the presence of chronic 
drug use (Koob and Le Moal 2008). This pathway, which includes the hypothalamic-
pituitary-adrenal (HPA) axis as well as other stress-related areas such as the habenula and 
interpeduncular nucleus (IPN), is mediated in part by corticotropin-releasing factor, CRF, 
which has been shown to be involved not only in stress responses, but also in anxiety 
induced by nicotine withdrawal (Zhao-Shea, DeGroot et al. 2015, Pang, Liu et al. 2016). 
Perhaps 3.0g/kg ethanol activates other areas besides the VTA, specifically areas such as 
the IPN which not only contains CRF receptors, but also projects to the VTA (Zhao-Shea, 
DeGroot et al. 2015).   
 More studies are required to decipher the exact role of α6* nAChRs and how 
these play into behavioral reactions to ethanol, but this study uncovered an important 
distinction between ethanol effects on male and female mice, the differential role played 
by α4* nAChRs, and a potential indirect relationship between the VTA and alcohol 
reward at higher doses. This idea, explored further, could be used to develop gender-
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specific treatments if indeed there are such deep, potentially genetic, differences 
underlying alcohol’s effect on the reward pathway. 
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CHAPTER V: Discussion  
 The exact mechanism by which addiction develops remains unclear, but the 
breadth of the disease is unmistakable. An estimated 22.7 million Americans age 12 and 
over are problematic drug and/or alcohol users or addicts, 9.9 million persons have driven 
under the influences of illicit drugs in the past year, 28.7 million have driven under the 
influence of alcohol in the past year, while only about 2.5 million received treatment as of 
2013 (SAMHSA 2014). The effects of addiction reach much further than the addict, 
impacting their loved ones, increasing violence and child neglect, increasing the risk of 
traffic accidents while under the influence, leading to absenteeism in the workplace, and 
place an economic burden on society as a whole (WHO 2015).  
 Addiction is likely a combination of a genetic and/or physiological disposition 
mixed with social and environmental influences (Lenz, Muller et al. 2012). Although the 
human condition of addiction is vastly more complex than anything we can recreate in an 
animal model, exploring individual aspects of addiction such as drug intake, reward, and 
drug-induced activation of the reward pathway, allows us to shed light on the biological 
underpinnings of the devastating human disease. In order to tease out the contributions of 
genetic makeup and environmental influences, we employed genetic mouse models 
including two nAChR knockout mouse lines, α4 KO and α6 KO, as well as a 
hypersensitive nAChR knock-in mouse, Leu9’Ala. While these genetic mouse models are 
incredibly powerful tools in exploring the contributions of nAChRs in alcohol use and 
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abuse, they are not without issue. Knockout mice develop without a specific nAChR 
subunit, allowing for potential compensation issues. For example, α4 KO mice, lacking 
the α4 subunit, have significantly less α6 expression, measured by immunoprecipitation 
with epibatidine, while α6 KO mice actually have higher α4 expression (Champtiaux, 
Gotti et al. 2003). There are also instances of functional compensation, in which some 
other cells not normally involved in a given action could change their function in order to 
compensate for the missing subunit, or the compensation could be present but masked 
entirely by partial redundancies already in place (Picciotto and Wickman 1998).  The 
hypersensitive mouse line, Leu9’Ala, creates an exquisitely sensitive receptor, one which 
is not physiological in its activation.  
 There are other technologies available that can circumvent some of these issues, 
including small interfering RNAs (siRNAs) that could be used to knockdown gene 
expression in adult animals, minimizing compensation that arises from developmental 
absence of a receptor subtype, but this would require a more localized target. In our case, 
a global knockout allowed us to explore the potential role of nAChRs in alcohol reward 
in general before narrowing down the target areas for exploration. Other tools available 
include optogenetic activation or deactivation of neurons using light-gated channels, 
channelrhodopsin and halorhodopsin, respectively, allowing temporal control of neuronal 
activation as well as spatial and the ability to recreate a behavioral phenomenon simply 
by activating or inhibiting a specific subset of neurons (Tsai, Zhang et al. 2009).  
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 Not all drug users become addicted, and not all reward leads to addiction, but 
behavioral assays such as operant self-administration can be used to predict the 
problematic drug use patterns that may lead to addiction, and allow researchers to study 
the transition from abuse to addicted (Becker and Koob 2016). Other assays, such as 
conditioned place preference  (CPP) and drinking-in-the-dark (DID), allow for the 
exploration of drug use from reward and intake angles, allowing the different aspects of 
drug use and eventual abuse and/or addiction to be separated. All assays have caveats, 
however, and behavioral assays are especially prone to outside factors influencing the 
results of the test. For example, a CPP in response to alcohol looks the same as a CPP to 
the chamber associated with alcohol, as that is what is actually measured. If the CPP is to 
the light, smells, sounds, etc. of the chamber, and not to the drug itself, it could result in a 
false-positive result. As such, all CPP experiments are counter-balanced to account for 
this, and initial chamber bias is taken into account when assigning the drug-paired 
chamber. With each animal receiving alcohol in the initially non-preferred chamber, it is 
unlikely that any initial bias would affect results in a positive manner; any CPP resulting 
in the initially non-favored chamber must first overcome the initial bias against the 
chamber. Every effort is made to reduce initial bias differences between the two 
conditioning chambers, the white and black chambers, to ensure a fairly even number of 
animals having each of the two as their drug-paired chamber, but it is in the nature of the 
animals to seek out the darker, black chamber, and that chamber is often the initially 
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preferred and thus vehicle-paired. This could affect the results as the animals may 
develop a CPP more easily to the white chamber based on sounds or smells, for example, 
but this was not seen in initial troubleshooting of the assay and would surface in the 
saline-saline control assays wherein the animal receives saline in both chambers.  
 Although the predominant areas in the pathway are the VTA, NAc, and PFC, 
there are other critically involved regions that influence this pathway. Projections from 
the lateral dorsal tegmentum (LDTg) and the pedonculopontine tegmentum (PPTg) to the 
VTA provide ACh, Glu, and GABA. The lateral hypothalamus sends GABAergic 
projections to VTA DA neurons, as does the lateral habenula. It has also been shown that 
the interpeduncular nucleus (IPN) has GABAergic projections onto VTA DA neurons, 
which in turn release corticotropin releasing factor (CRF) in the IPN (Zhao-Shea, 
DeGroot et al. 2015). Amazingly, this is still a simplified version, as many of the 
projections are neuron- and region-specific. For example, the PFC Glu projections into 
the VTA synapse exclusively onto DA neurons which then project to the NAc, and not 
onto those which project back to the PFC, creating a series of direct and indirect circuits 
within the reward system itself (Fields, Hjelmstad et al. 2007). Each target of the VTA 
receives projections from a distinct neuronal population within the VTA , adding even 
more to the complexity of this circuit (Fields, Hjelmstad et al. 2007).  
 Given the increase in ACh seen concurrently with the alcohol-induced increase in 
NAc DA (Larsson, Edstrom et al. 2005), it seems likely that the LDTg and/or PPTg may 
!108
be influenced by ethanol as well, although this has yet to be shown. It could be that the 
increased ACh is correlated but not causal, or perhaps the activated DAergic neurons, 
presumably those causing the increased DA in the NAc, are unable to bind ACh as the 
receptors are already either in the active or desensitized state, precluding ACh binding; if 
enough of the ACh receptors are unavailable, the ACh levels may seem elevated. We 
hypothesize instead that once the ACh is in the VTA, alcohol potentiates the response of 
DA neurons to ACh via nAChRs. We have previously shown that alcohol does indeed 
potentiate the response to ACh, though males and females were not investigated 
separately, and have seen that both α4* and α6* nAChRs play a role in this response (Liu, 
Hendrickson et al. 2013, Liu, Zhao-Shea et al. 2013). Although I did not see the same 
reliance on α6* nAChRs in activation of the VTA following alcohol, the 
electrophysiological approach used in the previous studies explored a temporally 
controlled response, a weak point of c-fos, although in an incomplete circuit whereas in 
the c-fos experiment, alcohol was delivered in a whole animal before the brain was 
sliced.  
 Interestingly, the nAChR subtypes involved are likely different in males and 
females. In males, α4* nAChRs are required for alcohol reward and alcohol-induced VTA 
activation, and play a role in alcohol consumption (Liu, Hendrickson et al. 2013), but  α4 
KO females show more robust reward than their WT counterparts (MGD unpublished). 
Both sexes seem to involve α6* nAChRs in alcohol sensitivity (Guildford, Sacino et al. 
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2016), with α6 KO of both sexes showing no CPP with 3.0g/kg, while their WT 
counterparts did.  Perhaps males rely on an α4α6* nAChR mechanism, while females use 
a non-α4, α6* nAChR mechanism to modulate activation of the VTA and increase DA in 
the NAc. These possibilities could be explored either using double knockout animals, 
lacking both α4 and α6 subunits, or by knocking each subunit down in adult animals to 
explore the effects of alcohol on NAc DA release.  
 The c-fos activation data presented here suggest that activation of the VTA is not 
necessary for alcohol CPP, at least in females, where we saw no significant increase in 
activation with 2.0g/kg, a dose which induced CPP in (α6) WT. In males, this dose led to 
both activation and CPP in WT (Guildford, Sacino et al. 2016). Additionally, female α6 
KO animals showed significant c-fos activation following 3.0g/kg ethanol, a dose that did 
not condition a place preference in these animals. This disconnect in females suggests 
alcohol may cause reward without appreciably activating DAergic neurons in the VTA, 
perhaps acting via a separate system entirely, or there may be a temporal issue in seeing 
this effect. As c-fos is not a particularly temporally sensitive measurement of activation, 
being measured about 90 minutes after an alcohol challenge, it is possible the activation 
may have occurred outside our experimental timeline.  A more precise measure of 
neuronal activation would be to use calcium or voltage sensors.  
 The discordant female data could be interpreted a different way, where rather than 
acting as the accelerator, alcohol could lead to activation of the reward pathway by 
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instead removing the brakes on the system. Dopaminergic neurons in the VTA are 
tonically inhibited by GABAergic interneurons (Burkhardt and Adermark 2014); thus, 
rather than directly activating DA neurons, or even indirectly activating them via 
potentiation of serotonin or ACh, alcohol may in fact be inhibiting inhibitory GABAergic 
inputs onto DA neurons, thus disinhibiting these neurons (Gremel and Cunningham 2008, 
Morikawa and Morrisett 2010, Bahi and Dreyer 2012, Soderpalm and Ericson 2013, 
Burkhardt and Adermark 2014).  It has been shown that alcohol decreases the firing rate 
of GABAergic neurons at the same dose that is shown to activate DAergic neurons, and 
stimulating these GABAergic neurons leads to decreased DA release in the NAc 
(Burkhardt and Adermark 2014).  Antagonism of GABA A receptors in the VTA not only 
leads to increased NAc DA (Soderpalm and Ericson 2013), but rodents will even self-
administer these antagonists in the VTA (David, Durkin et al. 1997).  Although there is a 
correlation between decreased VTA GABA and increased NAc DA, the DA increase has 
been shown in the absence of, or prior to, the GABA decrease (Burkhardt and Adermark 
2014).  It is likely that the role of GABA changes over the course of the addiction 
process, perhaps important more in maintenance than initiation/intoxication (Burkhardt 
and Adermark 2014).  
 α4* nAChRs are found on GABA neurons in the VTA, but α6* nAChRs are not, 
indicating that there could also be differential neuronal subtype involvement in each sex 
where these GABAergic neurons containing α4* nAChRs could be involved more in one 
!111
sex than the other, accounting in part for the reliance on the α4 subunit in males but not 
females. This idea could be investigated using selective activation or inhibition of 
GABAergic neurons via optogenetics, wherein an animal expressing Cre recombinase 
only in GABAergic neurons is given an intra-VTA injection of a floxed, light-gated virus, 
allowing light to be used to either activate or inhibit these neurons, depending on the 
channel used in engineering the virus (Tsai, Zhang et al. 2009).  
 Additionally, α6* nAChRs are found predominantly on the terminals of DAergic 
neurons projecting from the VTA to the NAc, which could affect the c-fos data as we 
looked in the cell bodies in the VTA and not the NAc terminals. Therefore, an absence of 
VTA activation at the DAergic cell bodies in α6 KO may not reflect the role of α6* 
nAChRs in modulating dopamine release in target areas at the terminal level. This could 
be explored by measuring alcohol-induced DA release in the NAc in α6 KO and WT 
mice, given that these receptors would be more prominent in this that in activation of the 
VTA DAergic neurons.  
 Whatever the role of these nAChRs are in the VTA and/or NAc, it is important to 
also note that the vast majority of research done prior to this was done solely in males, 
and there is much work to be done in females. In this study, we started the female 
exploration at the same point we had reached with our male studies, with the assumption 
that nAChRs were involved in alcohol consumption and reward. We perhaps could have 
benefitted from employing pharmacological studies using mecamylamine to first 
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determine if there were, in fact, any role for nAChRs. Kamens et al. (2010), however, 
showed a role for α7* nAChRs in alcohol intake in females only, suggesting there may be 
a role for these nAChR subtypes in females. Given the results in the present study, there 
is more background research to be done in whether nAChRs do, in fact, play a role in 
other alcohol-related behaviors before proceeding with additional specific probes.  
 While sex differences in human alcohol addiction involve societal and other 
environmental influences, dependence and reward in animals can be studied empirically 
to uncover purely genetic components. For example, by moving the testosterone-inducing 
Sry gene from the male Y chromosome onto an autosome, Barker et al. (2010) were able 
to investigate the role of genes and hormones separately by allowing independent 
assortment of this normally male-only gene. Creating XY gonadal females and XX 
gonadal males allowed separation of the two components, ultimately showing a role for 
both in striatal differences between normal genetic males and females (Barker, 
Torregrossa et al. 2010).   
 Genetic differences stem not only from the presence or absence of the Y 
chromosome or the Sry gene, but from the presence of one X versus two. With two X 
chromosomes, females often experience X-silencing, wherein in certain cells, only one X 
chromosome's genes are expressed. A female will have inherited one X chromosome 
from her mother and one from her father, and thus either, or both, could be expressed in 
each cell. In males, there is only one X chromosome and thus no need for X-silencing. 
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This X is only from the mother, as the father contributes a Y to all sons, and thus all X-
related genes will be from the mother alone. This X-silencing, or lack thereof, could 
influence the expression, and levels, of important genes for alcohol abuse or addiction 
(Sanchis-Segura and Becker 2016).  
 Additionally, males and females have different hormones and different levels of 
shared hormones, including estrogen and testosterone. These hormones have been shown 
to interact with alcohol (Lenz, Muller et al. 2012), and with various receptors found in the 
reward pathway (Becker and Hu 2008, Lenz, Muller et al. 2012, Agabio, Campesi et al. 
2016, Carroll and Lynch 2016), which could be involved in the sex differences, but with 
alcohol also able to modulate expression of these sex hormones, the reciprocal 
relationship makes it difficult to determine a causal relationship.  
 These sex differences, though unknown in their exact origin, should also be 
reflected in the treatments offered for alcohol use disorders. Treatments available now are 
not only ineffective and riddled with adverse side effects in many cases, but they also are 
based on studies done mainly using male subjects. It has been suggested that females may 
be more susceptible to the negative reinforcing effects of nicotine than males, with 
females more likely to relapse in response to withdrawal and negative affect (O'Dell and 
Torres 2014).  Dysregulation of stress response system, including the hypothalamic-
pituitary-adrenal (HPA) axis and the CRF system, has been shown with chronic drug use, 
and stressors that activate this system are also factors in the initiation of, or reversion 
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back to, drug use (Bobzean, DeNobrega et al. 2014). Interestingly, this stress response 
system is regulated by ovarian hormones, which is compatible with the idea that females 
may use drugs to avoid negative outcomes rather than in pursuit of positive outcomes 
(Bobzean, DeNobrega et al. 2014, O'Dell and Torres 2014). With CRF already implicated 
in nicotine-withdrawal-induced anxiety, and the reciprocal connection between the CRF-
containing IPN and the VTA, it is certainly possible that CRF and the IPN could play a 
role in the switch from positive- to negative-reinforcement of alcohol, and thus may also 
be involved in the sex differences seen in the reinforcement behind alcohol use (Zhao-
Shea, DeGroot et al. 2015).  
 With different reasons for drinking, different behavioral and physiological 
responses, and different hormones to contend with, there should be different treatments 
available; the more specific and targeted the treatment, the less likely they are to cause so 
many treatment-ending side effects, and the more likely they are to successfully treat 
those suffering from addiction.  
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